SUBSTANCE CARRYING CONGLOMERATE

Abstract: A conglomerate of controlled relative density carrying or for carrying at least one active substance for use in a fluid, a method of producing said conglomerate, a fluid bed reactor using such conglomerates, and use of said conglomerate e.g. in solid phase processes, in materials for treating waste water and polluted waters, and in materials for foods, medicals, and vaccines for fish and other animals living in water.

Description: SUBSTANCE CARRYING CONGLOMERATE 1. BACKGROUND OF THE INVENTION The Technical Field The invention relates to a conglomerate of controlled re¬ lative density with respect to a fluid, for carrying or carrying at least one active substance to be used in a fluid, methods of preparing such a conglomerates, and the use of such a conglomerate or particles of conglomerates as a solid phase matrix, carrier, or substrate material in a fluid bed rector; or in a batch reactor; as a carrier of substances for sustained release; as a food material, me- dical, and vaccine for fish, or other animals living in water; as a material for treating waste water and polluted waters; and as a material for treating polluted water such as oil poluted sea water; a method of distributing a fluid in a fluid bed reactor and a fluid bed reactor. In the present context the expression "conglomerate" is intended to designate a composite of basic particles, which may comprise particles of different types and sizes, held together by conglomerating agents. Conglomerates may be of various sizes, and shapes and should preferably exhibit various degrees if mechanical rigidity depending on the application. Further, conglomerates may be chemically active or may be chemically inactive under the conditions applied. The expression "conglomerate of controlled relative den¬ sity" is intended to designate a conglomerate or a conglo¬ merate particle for which in particular the basic parti¬ cles are chosen in predetermined amounts to provide a cer- tain relative density of the conglomerate with respect to the fluid in which an active substance or another consti- tuent of the conglomerate is to be used so that the floa- tability or sedimentation, respectively, is controlled. Thus, conglomerates according to the invention are inten¬ tionally designed with respect to the density of the me- dium for their particular purpose of application, inclu¬ ding proper consideration of the influence of their sizes on their floating or sedimentation properties. In other media, e.g. during preparation or during storage under e.g. dry conditions, the conglomerate may have a density different from than that in the fluid medium of use, such fluids may be liquids or gases. In the present context the expression "active substance" should be taken in a very broad sense comprising agents having desired properties for their particular purpose of application, e.g. adsorbents, ligands, reagents, enzymes, catalysts; natural substances and substrates, cell aggre¬ gates; or nutritional matter for animals living in water; entrapped in or chemically, e.g. covalently, ionically, photochemically, etc. bound to the conglomerate of con¬ trolled density. Carrier materials for carrying at least one active sub¬ stance are used in a wide variety of applications in che- mical and biological processes, such as production and ma¬ nufacturing of chemical or pharmaceutical products, e.g. for carrying catalysts in liquid phase oil conversion technology, for carrying enzymes for modifying synthetical products, e.g. enzymes such as proteases, invertases, ami- dases and ring forming enzymes for synthesis of lactones, and σarboxypeptidase for synthesis of peptides using so¬ lid-phase techniques; fermentation and cell growth, e.g. for carrying cells or substrate; waste water purification, e.g. for carrying enzymes and/or microorganisms, catalysts or adsorbents; chromatographic processes, e.g. high per¬ formance liquid chromatography, gel filtration, ion exchange and affinity chromatography, e.g. for carrying adsorbents; diagnostic processes, e.g. for carrying adsorbents for blood purification, dye chromatographic processes for albumine purification; and prophylactic pro- cesses, e.g. for carrying immobilized antibodies or an¬ tigens in extracorporal circulations for removal of an¬ tigens or antibodies, bacterial toxins or other toxins, and autoimmune diseases. Prior Art Disclosure There are numerous disclosures in the prior art concerning particles prepared from organic and inorganic materials. However, carriers comprising conglomerates of controlled relative density with respect to the fluid of use car¬ rying or for carrying at least one active substance have apparently never been disclosed. Kuraray Co., Ltd., C.A. 98:157436t discloses beads, par- tides, fibres, sheets, and tubes of glass, activated car¬ bon, silica, alumina or high molecular weight substances coated with copolymers of acrylates and carboxylic acids or amines to form selective adsorbent carriers or supports for use in selective electrodes or in column chromatogra- phy. Sakuma et al., C.A. 111:74363c, disclose glass or polymer spheres coated with hydroxyapatite for use as a stationary phase for column chromatography. EP-A-0266580 discloses a method for coating solid parti¬ cles with a hydrophilic gel preferably agarose for various separating processes in packed columns based on adsorbent groups, e.g. ion exchanging groups, hydrophobic groups, or groups with biospecificity chemically bound to a gel. Such coating may be provided by mixing hydrophilic solid particles with a gel-forming substance above the gelling temperature in which each individual particle is coated, separated from each other, and cooled below the gelling temperature, essentially to stabilize the particles ag- ainst the high pressure in e.g. HPLC applications. Generally, all of the above mentioned coated particles are provided by coating individual particles made of the same material and having the same density. US 4698317 discloses hollow microspherical glass particles having open pores, and being prepared by spray thermal decomposition of a solution, in an aqueous organic sol¬ vent, wherein the water content promotes open pore forma- tion. US 2797201 discloses substantially spherical, hollow par¬ ticles having a "thin, strong skin" being prepared by thermal treatment of droplets of a solution of a film for- ming material, e.g. an organic polymer such as a phenol- formaldehyde resin, and optionally further containing a "blowing agent", i.e an agent generating gas at the eleva¬ ted temperature of the thermal treatment. GB 2151601B discloses porous hollow particles of an in¬ organic material and a composite material comprising such particles supporting a selected substance such as a chro- matographic organic gel. The porous hollow particles may be formed by coating a fugitive core material, e.g. orga- nic resin beads or alginate spheres, with inorganic mate¬ rial, and then heating to remove the fugitive core mate¬ rial. Further, GB 2151602B discloses closely similar par¬ ticles wherein a magnetic material, such as ferric oxide, nickel oxid or cobalt oxide, is incorporated in the inor- ganic shell of the particle. The 3M Corporation (USA) markets a number of types of sub¬ stantially impermeable, hollow micro-spheres of silicious material. For example synthetically manufactured soda-lime borosilicate glass micro-spheres marketed by 3 in a va¬ riety of size fractions. Also, permeable hollow spheres of siliceous material derived from fly-ash are provided by Fillite Ltd., Runσorn, England. However, none of the com¬ mercially available micro-spheres are conglomerates of controlled relative density according to the invention. EP-A-0021563 discloses a material suitable for thermoset- ting which includes a collection of hollow particles adhe¬ sively mixed with a thermosetting resin and which material may be converted by thermosetting in to a fused solid mass 3 having a density not greater than 0.5 g/cm . GB-A-2196252 discloses an oral, solid, pharmaceutical do¬ sage form comprising conventional matrix binders including starch and cellulose, or their derivatives, and a pharma- ceutically acceptable weighting agent, including inorganic compounds such as salts, oxides, or hydroxides of a metal, e.g. barium sulphate or ferrous oxide, suitable for oral administration to humans and for controlled release of a pharmaceutically active ingredient into the stomach. The controlled release unit may have any chosen density from about 2 g/ml to about 6 g/ml and may in case of a conven¬ tional pellet have a size from about 1 to about 1.4 mm, and in case of a tablet a size above 10 mm. Nothing is disclosed nor suggested about non-solid i.e. permeable or porous conglomerates of controlled relative density according to the invention. Furtermore, the described pharmaceutical dosage form consists of solid particles comprising a binder and a weighting agent soluble in gastic fluid which makes the pellet or tablet disintegrate shortly after ingestion. Generally, for a large number of applications, the active substance to be used in a fluid may only temporarily be available or accessible at the right places in the fluid. Thus, for inert carrier particles carrying active substan¬ ces and often showing large variations in dispersion pro¬ perties, e.g. sedimention or floatation, the active sub¬ stances may be carried in an uncontrolled manner e.g. down- or upwards in relation to the fluid depending on the relative density of the carrier. In fluid bed reactors partially solving the problems of packed bed columns, i.e. the problems of suspended matter clogging up the solid-phase bed which increases the back pressures and compresses the bed disturbing the flow through the bed, the carrier particles are carrying the active substance in a free, fluid phase by applying a flow having an opposite direction to the direction of the rela¬ tive movement of the carrier. Thus, carrier particles having a density larger than the fluid and moving down- wards due to gravity may be kept in a free, fluid phase by an upwards flow of fluid. Also, carrier particles having a density less than the fluid and thus moving upwards may due to buoyancy be kept free, fluid phase by a downwards flow of fluid. For fluid bed solid-phase chemical processes, the density of the solid-phase carrier particle is very important in controlling bed properties. However, up to now, the design of solid-phase carrier particles has been limited by the available material. Generally, particles may either be designed to be imper¬ meable to the fluid, in which case the available surface area per unit volume is small; or particles may be desig- ned to be permeable to the fluid, in which case the mate¬ rial chosen has to have the correct density per se. Unfor- tunately, the most interesting materials for many appli¬ cations, e.g. materials such as natural and synthetic po- lysaccharides like agar, alginates, carrageenans, agaro- se, dextran, modified starches, and celluloses; synthetic organic polymers and copolymers typically based on acrylic monomers used for chromatographic purification of proteins in packed bed columns are not of suitable density per se. Therefore, these materials are difficult to apply in fluid bed reactors. However, certain types of organic polymers and certain types of silica based materials may be produced to provide carrier particles of suitable density, but such carriers may not at the same time be suitable active substances, e.g. for protein purification procedures, where such ma¬ terials may provide low permeability, non-specific inter¬ actions and denature bound proteins. Further, for such polymers, it may be difficult and expensive to design de- rivatisation schemes for affinity chromatography media. Also, certain types of permeable silica particles have been used for fluid bed applications. However, the pro¬ perties of these materials are far from optimal. Thus, the materials are instable at pH above 7, fragile to shear forces, and provide non-specific interactions. US 4032407 discloses a tapered bed bioreactor applying im¬ mobilized biological catalysts or enzymatic systems on fluidizable particulate support materials consisting of coal, alumina, sand, and glass, i.e. materials heavier than the fluid. EP-A-0175568 discloses a three phase fluidized bed bio¬ reactor process comprising purifying effluents in a three phase fluidized bed comprising solid particles being made by mixing a binder with an inorganic material based on aluminum silicate, granulating the resulting mixture, and firing the granules to sinter them. The specific gravity of the sintered granules is adjusted to fall into a spe¬ cific range from 1.2 to 2.0 by varying the mixing ratio of inorganic powdery materials based on aluminum and binders, said sintered granules having a diameter from 0.1 to 5 mm. EP-A-0025309 discloses a downflow fluid bed bioreactor applying biota attached to carrier particles consisting of cork, wood, plastic particles, hollow glass beads or other light weight material and having a specific gravity which is less than that of a liquid sprayed onto the upper part of a fluid bed of suspended carrier particles and conduc¬ ted downward through the bed. These three disclosures describe particulate support ma¬ terials to which the attachment of the active substance is restricted to the surface of the particles limiting the amount of active substance to be obtained per unit volume compared to particles allowing the active substance to be attached within the particle. Thus, in many applications, it is important to have specifically designed particles able to carry as large an amount of active substance per unit volume as possible which particles are not available in the prior art. Thus, in great many applications of active substances in fluids, there is a need for materials of controlled rela¬ tive density carrying or for carrying active substances in the fluids. Further, a disadvantage of distributing an introduced fluid in a fluid bed reactor by spraying is the formation of channels in the bed by fluid rays. EP-A-0005650 discloses an up-flow fluid bed reactor hav¬ ing fluidizing fluid flow distributors at the bottom thereof providing flow paths to avoid turbulens effects. Besides requiring complicated flow paths, a disadvantage of such a distributor is that it may be clogged by parti- culate matter. US 4142969 discloses an oleospecific hydrophobic composi¬ tion comprising an intimate mixture of expanded volcanic glass consisting of perlite, a cellulose fiber, and a wa¬ ter repellent sizing consisting of asphalt; and a method of sorbing oleaginous compounds e.g. in selectively remo¬ ving oil from the surface of water. The constituents are incorporated into a homogeneous product by a wet process, dried in an oven until essentially all moisture has been removed, and then ground up into a fluffy low density ma- terial. Nothing is disclosed nor suggeted about contolling the density of the composition by incorporation of high or low density particles. 2. DISCLOSURE OF THE INVENTION (a) Conglomerates In its broadest aspect, the object of the present inven¬ tion is to provide a conglomerate for carrying or carrying at least one active substance to be used in a fluid and having a controlled relative density with respect to the fluid. Particularly, it is the object of the present invention to provide conglomerates avoiding the disadvantages of known carrier materials, e.g. the problems of uncontrolled sedi¬ mentation or floatation of active substance and/or its carrier, the poor selectivity and capacity of carriers having immobilised active substances, and the missing pos- sibilities of simultaneously designing and controlling the properties of the active substance and carrier. Particularly, in one aspect of the invention, the object is to provide a conglomerate of controlled relative den¬ sity with respect to a fluid, for carrying at least one active substance to be used in the fluid, which object is fulfilled by providing such a conglomerate, comprising predetermined amounts of: a) basic particles consisting of at least one low density particle, preferably hollow, and/or at least one high density particle, said particles preferably impermeable to the fluid; and b) at least one conglomerating agent. Also, in another aspect of the invention the object is to provide a conglomerate of controlled relative density with respect to a fluid, carrying at least one active substance to be used in the fluid, which object is fulfilled by pro¬ viding such a conglomerate, comprising predetermined amounts of: a) basic particles consisting of at least one low density particle, preferably hollow, and/or at least one high density particle, said particles preferably impermeable to the fluid; b) at least one conglomerating agent; and c) said active substance. Thus, a conglomerate comprising basic particles having low and/or high densities, and further comprising at least one active substance and at least one conglomerating agent for conglomerating said basic particles and substance, the conglomerating agent itself optionally being an active substance, and all constituents in suitable predetermined amounts, provides a conglomerate of controlled density, particularly a conglomerate of controlled density with re¬ spect to the fluid to be used. Thus, by choosing the amounts appropriately, the relative density of the conglo- merate with respect to the fluid to be used can be con¬ trolled within the limits suitable for the application. Particularly, a conglomerate not comprising the active substance as such may be prepared separately in order to provide a material of controlled relative density which can be treated to comprise the active substance. According to the invention, conglomerates may further comprise other substances such as additives, fillings, softeners, etc., and may be designed to e.g. controlled release (also known as sustained release, slow release or "retard" release) of a desired substance from a conglome¬ rate depending on the choice of conglomerating agent, and possibly comprising a suitable surface coating, e.g. of a material such as the ones mentioned for the conglomerating agent, having diffusion or permeability characteristics appropriate to the gradual release of the substance in question from the conglomerate. In its broadest aspect the density may be controlled by selecting basic particles from a group of particles con¬ sisting of particles of very low density, particularly hollow and impermeable particles having shells of suitable material and properties, however, non-hollow particles may be chosen when appropriate; and particles of very high density, e.g. particles based on suitable heavy elements or compounds. Generally, the invention provides a new type of carrier particles comprising conglomerates of controlled relative density, selectivity, and capacity in terms of control- lable interior surface areas and materials e.g. materials having specific chemical and/or mechanical properties. Thus, compared with known carrier particles for fluid and packed bed reactors, conglomerates according to the inven- tion can surprisingly be designed to have a number of advantages not previously obtained. According to the invention, carrier particles can be de¬ signed to have a controlled relative density independent of the active substances and the conglomerating agents; heavy particles can be made light, and vice versa, within a wide range of particle sizes; the density can be con¬ trolled within very broad limits, e.g. the density of a known material can be controlled for a specific applica- tion; the volume percentage of the conglomerating agent can be controlled according to the application; the total size of the final carrier particle can be controlled con¬ trary to known particles having uncontrollable sizes for specific densities suitable for particular rising and fal- ling velocities; further, conglomerates according to the invention have a relative larger capacity, i.e. a larger accessible volume, compared to e.g. known impermeable car¬ rier particles; also, in preparing such known impermeable carrier particles, the active substances to be applied are limited, e.g. limited to substances that can be attached to the particle surface. However, for conglomerates, both the impermeable carrier particles and the active substan¬ ces may be included, e.g. in form of entrapped particles or substances. Also, contrary to known particles having a given mechanical strength and density, the elasticity and the mechanical strength of a conglomerate can be control¬ led independent of the density. Further, pore sizes and e.g. biocompatibility can be controlled independently of the density in order to allow access to the interior of the conglomerate and to avoid denaturation e.g. of pro¬ teins. (b) Methods of Preparation Preparation of conglomerates according to the invention may be obtained by various methods known per se, e.g. block polymerisation of monomers; suspension polymerisa¬ tion of monomers; block or suspension gelation of gelfor- ming materials, e.g. by heating and cooling (e.g. of aga- rose) or by addition of gelation "catalysts" (e.g. adding a suitable metalion to alginates or carrageenans); block or suspension cross-linking of suitable soluble materials (e.g. cross-linking of dextrans, celluloses, starches or gelatines, or other organic polymers with e.g. epichloro- hydrine or divinyl sulfon); formation of silica polymers by acidification of silica solutions (e.g. block or suspension solutions); mixed procedures e.g. poly¬ merisation and gelation; spraying procedures; and fluid bed coating of basic particles. Thus, for particularly preferred embodiments according to the invention, conglomerates may be obtained by cooling emulsions of basic particles suspended in conglomerating agents in heated oil solvents; or by suspending basic par¬ ticles and active substance in a suitable momoner or co- polymer solution followed by polymerisation. "Preparation by Gelation/Polymerisation in the Emulsified State" In another aspect the invention provides a method of pre- paring a conglomerate of controlled relative density with respect to a fluid, for carrying or carrying at least one active substance to be used in the fluid, comprising a) mixing basic particles consisting of at least one low density particle, preferably hollow, and/or at least one high density particle, said particles preferably impermeable to the fluid, at least one conglomerating agent made of a material consisting of natural and synthetic organic monomers and/or polymers selected from the group consisting of: i) natural and synthetic polysaccharides and other car¬ bohydrate based polymers, including agar, alginate, carrageenan, guar gum, gum arable, gum ghatti, gum tragacanth, karaya gum, locust bean gum, xanthan gum, agaroses, celluloses, pectins, mucins, dextrans, starches, heparins, gelatins, chitosans, hydroxy starches, hydroxypropyl starches, carboxymethyl star¬ ches, hydroxyethyl celluloses, hydroxypropyl cellu- loses, and carboxymethyl celluloses; ii) synthetic organic polymers and monomers resulting in polymers, including acrylic polymers, polyamides, po- lyimides, polyesters, polyethers, polymeric vinyl compounds, polyalkenes, and substituted derivatives thereof, as well as copolymers comprising more than one such organic polymer functionality, and sub¬ stituted derivatives thereof; and iii) mixtures of these; said active substance, if present, in predetermined amounts optionally heated; b) emulsifying said mixture in a suitable solvent; c) conglomerating by a suitable means such as gelation by heating/cooling, polymerisation of monomer or monomer mixtures, non-covalent or covalent cross-bonding and d) isolation and washing of the conglomerate. "Preparation by Gelation/Polymerisation in the Block Sta¬ te" In still another aspect, the invention provides a method of preparing a conglomerate of controlled relative densi¬ ty with respect to a fluid, for carrying or carrying at least one active substance to be used in the fluid, com- prising a) mixing basic particles consisting of at least one low density particle, preferably hollow, and/or at least one high density particle, said particles preferably impermeable to the fluid, at least one conglomerating agent made of a material consisting of natural and synthetic organic monomers and/or polymers selected from the group consisting of: i) natural and synthetic polysaccharides and other car¬ bohydrate based polymers, including agar, alginate, carrageenan, guar gum, gum arable, gum ghatti, gum tragacanth, karaya gum, locust bean gum, xanthan gum, agaroses, celluloses, pectins, mucins, dextrans, starches, heparins, gelatins, chitosans, hydroxy starches, hydroxypropyl starches, carboxymethyl star¬ ches, hydroxyethyl celluloses, hydroxypropyl cellu¬ loses, and carboxymethyl celluloses; ii) synthetic organic polymers and monomers resulting in polymers, including acrylic polymers, polyamides, po- lyimides, polyesters, polyethers, polymeric vinyl compounds, polyalkenes, and substituted derivatives thereof, as well as copolymers comprising more than one such organic polymer functionality, and substi- tuted derivatives thereof; and iii) mixtures of these; said active substance, if present, in predetermined amounts in a solvent; and b) conglomerating by a suitable means such as gelation by heating/cooling, polymerisation of monomer or monomer mixtures, non-covalent or covalent cross-bonding; and c) disintegrating the block of conglomerate; and d) segregating the particles, and washing the segregated conglomerate. Thus, e.g. for polysaccharides such as agarose and agar, i.e. materials melting at high temperatures and solidi¬ fying at low temperatures, the conglomerating means is by heating/cooling. Further, for aσryl derivatives and other monomers or mixtures of these, the conglomerating means can be selected from a group consisting of: a) addition of polymerisation catalyst; b) heating; c) illumination with light; and d) irradiation with ionizing radiation. Particularly for heavily charged polysaccharides and po- lymers such as alginates and carrageenans, the conglome¬ rating means is non-covalent cross-bonding by addition of a suitable metal ion. However, for polysaccharides in ge¬ neral, e.g. cellulose and its derivatives, and polymers containing e.g. amino, hydroxyl, thiol, and carboxy groups, the conglomerating means is covalent cross-bonding by addition of a suitable cross-bonding agent, e.g. epi- chlorohydrine, divinyl sulfon, bisepoxyranes, dibromopro- panol, glutaric dialdehyde, diamines, and other bifunc- tional agents. Also, the above mentioned conglomerating means may be com¬ bined in specific cases such as the preparation of con¬ glomerates of agarose-acryl-derivatives and cross-bonded mixtures of agarose and dextran. Further, in the above mentioned block polymerisation, the segregation step of the polymer block may be obtained by methods known per se, e.g. by granulation and sieving. (c) The Use of Conglomerates "Solid Phase Matrix, Carriers, or Substrate Materials" The invention also relates to the use of conglomerates ac¬ cording to the invention as a solid phase matrix, carrier, or substrate material in a procedure selected from the group consisting of: chromatographic procedures applying non-packed co¬ lumns including liquid chromatography, ion-exchange chromatography, and biospecific affinity chromato¬ graphy such as immunosorption and protein A chromato¬ graphy, and group specific affinity chromatography such as hydrophobic, thiophilic, dye, lectin, and me¬ tal chelate chromatography; filtration of a fluid medium; adsorption of at least one selected substance present in a fluid medium; heterogeneous catalysis of a reaction taking place in a fluid medium; immunochemical procedures, including immunosorbtion; solid-phase synthesis, including solid-phase peptide and protein synthesis, and solid-phase oli- gonucleotide synthesis; microbiological procedures; enzyme reactor procedures; carriage, on the outer or the interior surface of the particles, optionally after a suitable surface treat- ment of live cells selected from cells of human, animal, plant, fungal and microorganism origin. Examples of enzyme reactor procedures are: (i) "confinement immobilization" procedures making use of an enzyme (e.g. in the form of an enzyme solution) which is contained within the through-going pores and/or internal cavities of a permeable conglomerate, and which is prevented, as described earlier, above, from escaping from the conglomerate by the presence of a suitable sur¬ face coating having diffusion or permeability characteri¬ stics such that the desired enzyme substrate(s) and re¬ sulting reaction product(s) may migrate through the coat¬ ing; (ii) "solid-phase covalent immobilization" procedures ma¬ king use of an enzyme which is covalently bound, via ap¬ propriate functionalities, within the conglomerate, the resulting conglomerate optionally being subjecteu to a surface treatment to provided a coating of the type men¬ tioned in (i) above. Such procedures might be employed, for example, in the production of high-fructose syrups from sucrose molasses, using a permeable conglomerate containing a suitable "con- finement immobilized" or "solid-phase covalently immo¬ bilized" sucrase. "Fluid Bed Reactors" Generally, a fluid bed reactor may comprise a vertical re¬ actor with an inlet, an outlet, a fluid bed of particles, and a fluid. The fluid is introduced at the inlet and dis¬ persed, optionally through a gas head in case of down-flow reactors, on the bed of particles which are suspended and fluidized by the fluid. The fluid it conducted through the bed and a pool of reacted and/or unreacted fluid is let out at the outlet. Down-flow fluid bed reactors have fluid inlet at the top of the reactor and fluid bed particles of specific gravity less than that of the fluid. Up-flow fluid reactors have fluid inlet at the bottom of the reactor and fluid bed particles of specific gravity larger than that of the fluid. The suspended particles may be reactive or may carry immo¬ bilized reactive components selected for solid phase che¬ mical or physical processes with one or more components of the fluid in procedures such as enzymatic reactions; fer¬ mentation; ion-exchange and affinity chromatography; fil¬ tration; adsorption; catalysis; immunosorption; solid-pha¬ se peptide and protein synthesis; and microbiological growth of microorganisms. It is an object of the invention to provide the use of conglomerates according to the invention in solid-phase chemical processes such as heterogeneous chemical reac¬ tions in continuous fluid bed reactors particularly for separation of proteins. Accordingly, the invention provides the use of a conglo¬ merate or particles of a conglomerate according to the in¬ vention, or a conglomerate prepared by a method of prepa- ring a conglomerate according to the invention, as a so¬ lid phase matrix, carrier, or substrate material in a fluid bed reactor. Generally, in order to carry out solid phase chemical or physical processes in a fluid bed reactor, an even and smooth distribution of fluid in the fluid bed is desired. However, fluid bed reactors known in the art do not have means known per se to avoid formation of channels as well as unwanted turbulens in the particle bed. It is another object of the present invention to provide a fluid bed reactor and a method of distributing a fluid in a fluid bed reactor such that the fluid is distributed evenly and with minimal or no turbulence in the fluid bed. According to the invention this is obtained by providing a method of distributing a fluid in a down flow fluid bed reactor comprising a vertical reactor with an inlet, an outlet, and a fluid bed of particles, wherein the parti- cles proximal to the fluid inlet are agitated, preferably by stirring with a mechanical stirrer which does not form a vortex, forming a mixing zone of dynamical particles adjoining a non-mixing zone where the particles are in stationary fluidized, said mixing zone having an extent determined by the degree of agitation the value of which is selected for a given flow of fluid, viscosity, and buoyancy of the particles, within a range from a degree of agitation where the particies move but to not mix to a degree of agitation where the particles mix throughout the fluid bed. Also, the invention provides a similar method for an up flow fluid bed reactor in which the extent of the mixing zone is determined based on the sedimentation of the fluid bed particles instead of the buoyancy of the particles as in case of the down flow fluid bed reactor. Specifically, the invention provides such method of dis¬ tribution a fluid in a fluid bed reactor wherein the par¬ ticles consists of a conglomerate or particles of a con- glomerate according to the invention. It is known that fluids and solids can be mixed by agita¬ tion. However, to the applicants knowledge, it is new to apply agitation to fluid bed reactors for the purpose of distributing the fluid flow in the fluid bed, particularly for a down flow reactor. Apparently, in the art, it has been anticipated that agi¬ tation of a fluid bed generates turbulence which may re- suit in unwanted mixing of products and reactants, and in unwanted wear of the bed particles. However, according to the invention, these disadvantages can be limited consi¬ derably by agitating a part of the fluid bed, particularly the part of the bed proximal to the inlet of the fluid. Particularly, for a down-flow fluidized fluid bed reactor it has turned out, that agitation of the upper part of the fluid bed divides the bed in two zones: i) a mixing zone with turbulence and dynamically moving particles; and ii) a non-mixing zone with no turbulence and particles in a stationary fluidized state. The two zones adjoin with a sharp interface across which fluid flow is evenly distributed. The position of the sharp interface is controlled by the degree of agitation which is selected for a given flow of fluid, viscocity, and buoyance /sedimentation of the particles. Thus, accor¬ ding to the invention, a mixing zone provides an even dis- tribution of fluid flow to the non-mixing zone with mi¬ nimal or no turbulence. A number of advantages are obtained. For chromatographic applications, the dispersion of eluant is reduced, i.e. the width of the eluation band is redu¬ ced. Also, for enzymatic and fermentation type reactions, enzyme inhibition is reduced as the intermixing of pro¬ ducts and substrates is reduced. Further, formation of channels in the fluid bed is minimized. According to the invention, agitation can be effected by stirring the fluid bed or by any agitation means, inclu¬ ding mechanical agitation or gas injection. According to the invention, the fluid bed particles can be different or of the same type for both the mixing zone and the non-mixing zone. In a preferred embodiment, the mixing zone may comprise inert particles of slightly different specific gravity than the particles of the non-mixing zone. In this case, the iner particles positioned in the mixing zone solely participate in the distribution of fluid, and not in the solid phase processes. The invention also provides a down flow fluid bed reactor comprising a vertical reactor vessel with an inlet, an outlet; a fluid bed of particles; and agitation means, preferably a mechanical stirrer which does not form a vor- tex, agitating the particles proximal to the fluid inlet so that a mixing zone of dynamical particles adjoining a non-mixing zone where the particles are in a stationay fluidized state, said mixing zone having an extent deter¬ mined by the degree of agitation the value of which is selected for a given flow of fluid, viscosity, and buoyancy of the particles, within a range from a degree of agitation where the particles move but to not mix to a degree of agitation where the particles mix throughout the fluid bed. Also, the invention provides a similar up flow fluid bed reactor in which the extent of the mixing zone is determi¬ ned based on the sedimentation of the fluid bed particles instead of the buoyancy of the particles as in case of the down flow fluid bed reactor. Generally, compared to packed bed techniques, fluid bed techniques, e.g. to be used in fluid bed chromatography, are better suitable to large scale primary purification of proteins as the steps of centrifugation and filtration can be avoided. Thus, the fluid bed techniques can be used immediately following the production of the protein, e.g. directly applying the produced extract or fermentation fluid to fluid bed purification and conversion. Accordingly, using conglomerates according to the inven¬ tion in fluid bed techniques, several advantages such as the control of the density, and the choice of materials to design the chemical and/or mechanical properties of the carrier particles, e.g. including cheaper basic materials, are obtained. "Batch Reactors " Another common way of performing solid phase reactions e.g. adsorption of at least one selected substance from a fluid medium in non-packed columns is by the way of ad¬ sorption in a batch reactor or batch column e.g. a simple vessel wherein the conglomerate particles are mixed with the liquid in a one-step procedure. In another aspect, the invention provides the use of a conglomerate or particles of a conglomerate according to the invention, or a conglomerate prepared by a method of preparing a conglomerate according to the invention, as a solid phase matrix, carrier, or substrate material in a batch reactor. Thus, an enhanced speed of separation of conglomerate par¬ ticles in a batch reactor process can be obtained by choosing an optimally controlled relative density of the particles. A particularly preferred way of separating the conglome¬ rate particles is to pump the liquid containing the par¬ ticles through a particle collection vessel which traps the particles e.g. by letting the particles with relative low density float up-wards in the vessel and letting the liquid flow through. 'Carriers of Sxibstances for Sustained Release" In another aspect the invention provides conglomerates of controlled relative density to be used for sustained re¬ lease of a desired substance from a conglomerate depending on the choice of conglomerating agent and specific ap- plication. Thus such conglomerates may comprise a suitable surface coating, e.g. of a material such as the ones men- tioned for the conglomerating agent. Further, the con¬ glomerates have diffusion or permeability characteristics appropriate to the gradual release of the substance in question. "Carriers of Substances for Animals Living in water" In still other aspects the invention provides conglome¬ rates of controlled relative density to be used in foods, medicals, and vaccines for fish, or other animals living in water, which substances may be administered most effi¬ ciently if they do not sediment on the bottom, where they may be lost or eaten by other animals. "Carriers of Substances for Waste Water Treatment " In still another aspect the invention provides conglome¬ rates of controlled relative density for waste water treatment materials, wherein the active substance is a mi- crobial cell, an enzyme, a catalyst or another treatment material purifying or at least partly purifying the water. Floating particles comprising waste water treatment material may have the advantage of oxygen being available for e.g. microorganisms growing in the interior of the conglomerate. "Carriers of Substances for Treating Oil Polluted Waters" In still another aspect the invention provides conglomera- tes of controlled relative density for treating oil pol¬ luted waters, wherein the active substance is a microbial cell capable of breaking down and feed on oil, or is a ca¬ talyst for breaking down oil and oil emulsions. The active substance may also comprise materials suitable for selective hydrofobic adsorption of oil, such as certain type of surface treated perlite. Thus, conglomerates for treating oil pollution may have the advantage of being designed to be in close contact with the oil or the oil emulsions at the water surface, e.g. confined within a certain area of the surface by means of pontoons. 3. BRIEF DESCRIPTION OF THE DRAWINGS The present invention is further illustrated by reference to the examples given below and to Figure 1-7, wherein Fig. 1A shows a 40X amplified photograph of conglomerates of agarose and glass spheres prepared according to Example 1(a); Fig. IB shows a 40X amplified photograph of selected sphe¬ rical conglomerates of agarose and glass spheres prepared according to Example 1(a); Fig. IC shows a 40X amplified photograph of conglomerates of acrylic acid copolymer and single solid glass spheres prepared according to Example 11; Fig. 2 illustrates a preferred embodiment of a fluid bed reactor; and Fig. 3 illustrates another preferred embodiment of a fluid bed reactor; Fig. 4A and 4B show perspective sketches of another pre- ferred embodiment of a down flow fluid bed reactor; Fig. 5 illustrate the fluid bed particles of conglomerates according to the invention in a down flow fluid bed reactor; Fig. 6A-6D illustrate cross-sections along the lines VIB, VIC, VID, VIE in Fig. 5; and Fig. 7 illustrates the collection of fluid bed particles of conglomerates according to the invention in a collec¬ ting vessel of a protein purification batch process. 4. DETAILED DESCRIPTION (a) Controlled Relative Density of Conglomerates Within the present context the expression "relative densi¬ ty of conglomerates" designates the density of the indi¬ vidual conglomerate particles in the wet state, i.e. a state where the conglomerating agent is fully hydrated, but without any interstitial liquid between individual conglomerate particles. This means that the liquid in which the conglomerate particles are used are determinant for the density of the conglomerate particles in as much as this liquid penetrates into the volume of the conglo¬ merating agent, solvates this and fill out the pores. Further, the expression "relative density of the par¬ ticles" designates the density of the particles relative to the density of the liquid in which the particles are to be used. This relative density is determinant for the tendency of the particles to float or to sediment in a gi¬ ven liquid. The relative density of conglomerate particles according to the invention is thus dependent on the sol- vated density of the conglomerating agent, the concentra¬ tion of conglomerating agent, the density of the basic particles (preferably impermeable to the liquid and sub¬ stantially non-solvated) used to regulate the density and the concentration of these. The density of the solvated phase, i.e. the volume occu¬ pied by the. conglomerating agent and the active substance will usually be dependent on the specific application of the particles and thus not allowable to be regulated by variation of the concentration of conglomerating agent. Therefore, according to the invention the density of the conglomerate particles is regulated by the addition of basic particles having a density free of choice with re¬ spect to the functionality of the conglomerate and also having a final concentration in the conglomerate free of choice with respect to the functionality, i.e. the func¬ tionality of the active principle within the volume of the conglomerating agent is not disturbed by the density and concentration of the basic particles. A crude estimate of the final density as a function of the concentration of basic particles can be found by the fol¬ lowing equation: Density of conglomerate= ((d x v ) + (d. x v v j ))/( v c + v b ^ dc - density of solvated conglomerating phase d. = density of basic particles v_ «s volume occupied by solvated conglomerating phase v, = volume occupied by basic particles. Differences in the degree of solvation occuring in dif¬ ferent solvents have to be corrected for. Thus, for cer¬ tain conglomerating agents, e.g. heavily charged polymers for ionexchange chromatography, the degree of solvation, i.e. the volume of liquid taken up per gram dry weight, may differ with several hundred percent in fluids with different ionic strength or pH. By way of example the density of conglomerate particles comprising agarose as the conglomerating agent and hollow glass spheres as basic particles is regulated by the ad¬ dition of hollow glass spheres to the liquified agarose, the amount added (for example measured as gram hollow glass spheres per ml agarose) being determinant for the density of the final conglomerate. Assuming a density of the agarose phase to be 1.0 g/ml and the volume used to be one liter (1000 ml) and the density of the hollow glass spheres to be 0.2 g/ml and the amount used to be 100 g (corresponding to 500 ml) the calculated density would be: ((1.0 x 1000) + (0.2 x 500))/(1000 + 500) = 0.73 g/ml If only 50 g of hollow glass beads were added the calculated density would be: ((1.0 x 1000) + (0.2 x 250))/(1000 + 250) = 0.84 g/ml If instead of the hollow glass spheres, the basic particles used were solid glass spheres with a density of 2.5 g/ml and 500 g were used to the same amount of agarose, the calculated density would be: ((1.0 x 1000) + (2.5 x 200) )/(1000 + 200) = 1.25 g/ml "Concentration of Basic Particles" Generally, the basic particle concentration shall be as small as possible in order to obtain as high a concen¬ tration of the active substance as possible. However, depending on the application, the basic particles concentration by volume is selected from a group consisting of: 1 - 95 % 1.5- 75 %, 5 - 50 %, 5 - 40 %, 5 - 30 %, most preferred. "Dimensions of Conglomerates" According to the invention, optimum dimensions of a con- glomerate of the types according to the present invention will largely depend upon the use to which they are to be put, although limitations dictated by the nature of the material and/or by the nature of the active substance and conglomerating agent within the conglomerate may also play a role. From the point of view of achieving the greatest rate of interaction of chemical species with a given mass of con¬ glomerate of a particular type, it will generally be ad- vantageous that the total surface area of the conglomerate is as large as possible, and thus that the size of the conglomerate is as small as possible. In preferred aspects of a conglomerate according to the invention, the size of substantially all of said conglome¬ rates is within a range selected from the group consisting of: 1-10000 nm, 1- 5000 am, 1- 3000 am, 1- 2000 urn, 1- 1000 urn, 50- 500 nm. The actual size preferred is dependent on the actual ap¬ plication and the desired control of the dispersion pro¬ perties, e.g. sedimentation and floatation, of the conglo¬ merate both properties being dependent on the density and the size of the conglomerate. Thus, for very fast separa¬ tion flow rates conglomerates of relatively low or high densities and relatively large sizes are preferred. Howev¬ er, large conglomerates may be limited in diffusion in certain applications, e.g. when proteins have to diffuse in and out of conglomerates and interact with active sub¬ stances within the conglomerate. Further, for conglomerates having the same density and si¬ ze the, the diffusion properties of molecules within the conglomerate may depend on the number of basic particles. Thus, for conglomerates having one basic particle, the diffusion length may be shorter than for conglomerates having many smaller basic particles. In general, conglome¬ rates of only one basic particle may be preferred when the molecular diffusion within the conglomerate is a limiting factor of the application. Thus, for purification and binding of proteins and other high molecular weight substances which may diffuse slowly in the conglomerate, e.g. in the conglomerating agent, the preferred size of conglomerates is within a range selected from the group consisting of: 100- 500 um, most prefered. Further, particularly for purification and binding of pro- teins and other high molecular weight substances in a batch process, the preferred size of conglomerate particles is within a range selected from the groups of: 500-1000 μm, most preferred. Further, for enzyme reactions in which an enzyme immobili¬ zed within the interior of the conglomerate reacts with a substrate of relatively low molecular weight, the prefered size of conglomerates is within ranges selected from a group consisting of: 200- 1000 μm, most preferred. Especially for immobilisation of microorganims, the pre- ferred size of the conglomerate is within ranges selected from the group consisting of: 0.5-50 mm 0.5-10 mm 0.5-5 mm, most preferred. For a conglomerate within the context of the present in¬ vention to be of use, for example, in chromatographic se¬ paration processes, the time-scale of the process of dif- fusion of fluid i.e. gaseous or liquid phases through the conglomerate, where relevant, should preferably be short in order to ensure sufficiently rapid equilibration be¬ tween extra- and intraparticular phases; this time-scale will often be of the order of seconds. (b) Basic Particles and Materials In selecting basic particles for use as low or high densi¬ ty particles according to the invention, the material of the particles depends on the purpose. Generally, the mate¬ rial is to be sought among certain types of natural or synthetic organic polymers, primarily synthetic organic polymers, inorganic substances and compounds, metallic elements, and alloys thereof, non-metallic elements, and gas bubbles. "Synthetic Organic Polymers" Among types of synthetic organic polymers which may pos¬ sibly be of interest are resins of the phenol-formaldehyde type and ABS resins, but other classes of synthetic orga¬ nic polymers, such as acrylic polymers, polyamides, poly- imides, polyesters, polyethers, polymeric vinyl compounds, polyalkenes and substituted derivatives thereof, as well as copolymers comprising more than one such said polymer functionality, and substituted derivatives of such copoly¬ mers, may well furnish suitable candidates. Particularly preferred low density basic particles are hollow plastic particles. "Inorganic Substances and Compounds" However, from the point of view of cheapness and ready a- vailability, in some cases it is advantageous to employ particles of inorganic material, especially since mate¬ rials with the greatest mechanical rigidity are generally to be found amongst inorganic materials. Thus, material of the basic particles employed in the conglomerate according to the invention may comprise a member selected from the group consisting of inorganic substances and compounds, metallic elements and alloys thereof, and non-metallic el¬ ements. In a preferred aspect, the material comprises a member se¬ lected from the group consisting of: anhydrous forms of silicon dioxide, including amor- phous silica and quartz; metal silicates, including silicates of lithium, so¬ dium, potassium, calcium, magnesium, aluminium and iron, and metal borosilicates, such as borosilicates of said metals, metal phosphates, including hydroxy- apatite, fluorapatite, phosphorite and autunite; metal oxides and sulfides, including magnesium, alu¬ minium, titanium, vanadium, chromium, manganese, iron, cobalt, nickel, copper and silver oxides; non-metal oxides, including boric oxide; metal salts, including barium sulfate; metallic elements, including magnesium, aluminium, titanium, vanadium, chromium, manganese, iron, co¬ balt, nickel, indium, copper, silver, gold, palla¬ dium, platinum, ruthenium, osmium, rhodium and iri- dium, and alloys of metallic elements, such as alloys formed between said metallic elements; crystalline and amorphous forms of carbon, including graphite, carbon black and charcoal. "Gas Bubbles" Further, in a preferred aspect the material of the basic particles may comprise gases such as air, nitrogen, carbon dioxide, or inert gases, e.g. He, Ne, Ar, Kr, and Xe, con¬ fined in a cavity. "Siliceous Glassy or Ceramic Materials" As mentioned earlier, the prior art discloses a number of examples of hollow particles of siliceous glassy or cera¬ mic material which may be used as low density hollow par¬ ticles of conglomerates according to the invention, these previously disclosed particles being obtained relatively cheaply and straightforwardly by deliberate synthesis or as a fly-ash by-product of certain combustion processes. Accordingly, in a further preferred aspect of the inven¬ tion, the material of the basic particles employed in con- glomerates of both low and high density particles accord¬ ing to the invention is a glass, preferably an synthetic glass comprising silicon dioxide and/or a silicate. In yet another preferred aspect of the invention, such ma- terial is a silicon dioxide-containing material derived from fly-ash, in which case the material may be amorphous (e.g. glassy) or crystalline, or to some extent both amor¬ phous and crystalline. "Magnetic Materials" For certain applications of a conglomerate, the material of the basic particles may comprise an appropriate amount of magnetic material e.g. for confining or retaining the conglomerate within a particular region of, for example, a process vessel or a chromatographic column, without the need for the incorporation of physical means of confine¬ ment or retention, such as a filter. Thus, a further aspect of the invention provides conglome- rates of basic particles of which the particles comprises a component selected from the group consisting of: paramagnetic metallic elements, including iron, co¬ balt and nickel, and paramagnetic alloys, including alloys containing said paramagnetic metallic ele¬ ments; metal oxides, including iron(II) oxide, iron(III) oxide, cobalt(II) oxide and nickel(II) oxide; metal salts, including cobal (II) salts, e.g. co¬ balt(II) phosphate, chromium(III) salts, e.g. chro- mium(III) fluoride, and manganese(II) salts, e.g. manganese(II) carbonate. "Basic Particle Structure' Further, the material of the basic particles within the context of the present invention may be chemically and/or physically inhomogeneous. For example, it may have a laye¬ red structure involving one or more layers of similar or different materials, e.g. various types of siliceous mate¬ rials. Alternatively, for example, it may consist of a si¬ liceous material, such as a siliceous glassy material, containing particles or regions with a high content of a metal oxide or a metallic element chemically reactive, e.g. as a catalyst. (c) Active substances Concerning the active substances to be introduced into the conglomerate according to the invention, this may, for ex- ample, be any type of material which is useful for a given application. Further, in one aspect of the invention the active substance may itself act as a conglomerating agent keeping the basic particles together and providing mecha¬ nical stability. In another aspect of the invention the material of an ac¬ tive substance comprises a member selected from the group consisting of organic and inorganic compounds or ions, me¬ tallic elements and alloys thereof, non-metallic elements, organic polymers of biological and synthetic origin, mem¬ brane-enclosed structures, biological cells, and virus particles. In a preferred aspect, the active substance comprises a member selected from the group consisting of: ligands known per se in the field of chromatography, e.g. charged species i.a. for ion exhange chromato- graphy; proteins, dyes, enzyme inhibitors, specific ligands for specific proteins, e.g. biotin for puri¬ fication of avidin and pther biotin binding proteins, carbohydrates for purification of lectins or glycosi- dases, protein A, chelates, e.g. iminodiacetic acid; amino acids, e.g. arginine, lysine, and histidine; sulfated polymers including e.g. heparins; gelatins; benzhydroxamic acid; hydrophobic ligands, e.g. phe¬ nyl, hydrocarbons such as octyl amine, octanol; thio- philic ligands, i.e. divinyl sulfone activated sub- stances coupled with mercaptoethanol or 4-hydroxy-py- ridine, 3-hydroxy-pyridine, 2-hydroxy-pyridine; lipid vesicles; microorganisms and enzyme systems; virus particles, including attenuated and inactivated virus particles; natural and synthetic polynucleotides and nucleic acids, including DNA, RNA, poly-A, poly-G, poly-U, poly-C and poly-T; natural and synthetic polysaccharides and other car¬ bohydrate based polymers, including agar, alginate, carrageenan, guar gum, gum arable, gum ghatti, gum tragacanth, karaya gum, locust bean gum, xanthan gum, agaroses, celluloses, pectins, mucins, dextrans, starches, heparins, and gelatins; natural and synthetic peptides and polypeptides and other amino acid based polymers, including albumins, hemoglobulins, immunoglobulins including poly- and monoclonal antibodies, antigens, protein A, protein G, lectins, glycoproteins such as ovomucoids, biotin binding proteins e.g. avidin and streptavidin, and enzymes e.g. proteases, and protease inhibitors; synthetic organic polymers, including acrylic poly¬ mers, polyamides, polyimides, polyesters, polyethers, polymeric vinyl compounds, polyalkenes, and substi- tuted derivatives thereof, as well as copolymers com¬ prising more than one such organic polymer function¬ ality, and substituted derivatives of such copoly¬ mers; food, medicals, and vaccines for fish and other ani¬ mals living in water; hydrated and anhydrous forms of silicon dioxide, in¬ cluding silica gel, amorphous silica and quartz; metal silicates, including silicates of lithium, so¬ dium, potassium, calcium, magnesium, aluminium and iron, and metal borosilicates, including borosili¬ cates of said metals; metal phosphates, including hydroxyapatite, fluorapa- tite, phosphorite and autunlte; metal oxides, including magnesium, aluminium, tita¬ nium, vanadium, chromium, manganese, iron, cobalt, nickel, copper, and silver oxides, and paramagnetic metal oxides, including iron(II), iron(III), co¬ balt(II) and nickel(II) oxides; metal salts, including barium sulfate, and paramagne- tic metal salts, including combalt(II), chromium(III) and manganese(II) salts; metallic elements, including magnesium, aluminium, titanium, vanadium, chromium, manganese, indium, cop- per, silver, gold, palladium, platinum, ruthenium, osmium, rhodium and iridium, and paramagnetic me¬ tallic elements, including iron, cobalt and nickel, and alloys of metallic and paramagnetic metallic ele¬ ments, including alloys formed between said metallic and paramagnetic metallic elements. "Introduction of Active Substance into Conglomerates" Generally, the active substance may be introduced into the conglomerate in a number of ways depending on the nature of the active substance, conglomerating agent, and the conglomerate itself, e.g. its pore size. Thus, both low and high molecular weight ligands may be incorporated du¬ ring conglomeration either by entrapment or by chemical cross-linking or by co-polymerisation. Further, both low and high molecular weight ligands may be chemically coup¬ led to a conglomerating agent before or after conglomera¬ tion, or they may be coupled to precursor monomers or po¬ lymers introduced together with the conglomerating agent during the conglomeration provided the desired functions of the active substance is kept intact or may be reesta¬ blished before use. However, if the means of conglomera¬ ting damages or destroys the functioning of the active substance, the fragile active substance may be introduced after conglomeration provided the conglomerate has been designed with suitable pore sizes to allow access to its interior. "Introduction via Liquid Media" Materials within several of the above categories, for ex¬ ample lipid vesicles, virus particles, certain polypepti- des, and certain metal silicates and other metal salts, may be introduced into the conglomerate in the form of solutions, suspensions or dispersions in suitable liquid media. "In Situ Formation/Sequential Introduction" Materials within some of the other categories, for example numerous polymers and copolymers, certain metal phospha¬ tes, certain metal oxides, e.g. silver oxide, and certain metallic elements, e.g. silver, may be introduced into the conglomerate by forming them in situ via a series of steps involving the sequential introduction into the conglomera- te of a series of reagent solutions; for example silver oxide might be deposited in situ within conglomerate by partially infusing them with an aqueous solution of a sol¬ uble silver(I) salt, e.g. silver(I) nitrate, and then par¬ tially infusing them with an aqueous solution of a base, e.g. sodium hydroxide. The liquid solvent(s) may then, if desired, be removed from the conglomerate by, e.g., sub¬ jecting the conglomerate to a vacuum treatment. "In Situ Formation/Thermal Treatment" In some cases it may be possible to form an active sub¬ stance in situ within the conglomerate by thermal treat¬ ment of a substance which has initially been introduced into or formed within the conglomerate via the introduc¬ tion of one or more solutions, suspensions or dispersions in liquid media, although this obviously will require that the material of the conglomerate Itself and the conglome¬ rating agent suffer no detrimental effects as a result of the thermal treatment; for example, it is well known that the noble metals platinum and rhodium can be formed in fi- nely divided, highly catalytically active form by heating almost any complex or binary compounds of the elements, e.g. (NH 4 ) 2 [PtCl β ] or (NH.) 3 [RhCl β ], at temperatures above about 200°C in the presence of oxygen or air. "Incorporation of Organic Polymers or Copolymers; In Situ Polymerisation" For the use of conglomerates according to the invention in various chromatographic procedures, e.g. ion exchange chromatography, and in other procedures, for example so¬ lid-phase peptide synthesis, the conglomerates in question may incorporate organic polymers or copolymers. By way of example, the application of a permeable conglomerate ac¬ cording to the invention to peptide synthesis employing the classical chemical methodology of Merrifield [see, e.g., Barany et al . Int . J. Peptide Protein Res. 30 (1987) pp. 705-739] will initially require the in situ formation αf a cross-linked styrene/divinylbenzene copolymer resin by polymerization of styrene monomer containing, typical¬ ly, about 1-2% of divinylbenzene; the resin may then be functionalized by subsequent treatment of the resin-con¬ taining conglomerate with solutions of the appropriate reagents. Thus, in a further aspect of a conglomerate according to the invention, the active substance comprises a polymer or a copolymer formed in situ within the conglomerate by a procedure comprising the steps of: immersing the conglomerate in a solution, in a liquid solvent or solvent mixture, of one or more components which can polymerize or copolymerize to form a poly¬ mer or a copolymer or mixtures thereof, the solution optionally containing a polymerization catalyst or initiator, allowing the solution to at least partly fill the conglomerate via the through-going pores, allowing the polymer-/copolymer-forming components to polymerize/copolymerize to form solid polymer(s)- /copolymer(s) therein, optionally substantially removing any liquid solution remaining within the conglomerate, optionally further treating the polymer-/copolymer- containing conglomerates as to: (i) at least partly chemically derivatize and/or mo- dify the polymer(s)/copolymer(s) within the conglo¬ merate and/or* (ii) introduce further components into the conglome- rate. "Incorporation of Fragile Active Substances" Materials other than those mentioned above may also con- ceivably be incorporated as components of porous conglo¬ merates; for example, for certain biotechnological appli¬ cations, such as the preparation of vaccines, antibodies or toxins, or cell cultivation for the production of me¬ tabolites (e.g. the production of ethanol by yeast cells) it may be desirable, according to the invention, to in¬ troduce live or dead cells of human, animal, plant, fungal or microoganism origin, or organelles (such as nuclei, mi¬ tochondria, chloroplasts or lysozomes) of similar origin, into conglomerates in situ. This will, of course, neces- sitate the provision of relatively large permeable conglo¬ merates having through-going pores of a suitably large size, e.g. of the order of ca. 5-20 μm in the case of se¬ veral types of human cells such as it will then often be necessary or desirable, after the introduction of such cells or organelles, to coat the resulting conglomerates by a suitable treatment, so as to retain the cells or or¬ ganelles within the conglomerates but allow migration of smaller species into or out of the conglomerates. This may be done by coating the conglomerates with a suitable mem- brane material having a suitable permeability. "Pore Sizes and Their Formation" The optimum size or size-range of the through-going pores will, of course, vary very considerably, depending on the use to which the permeable conglomerate is to be put. Such pore sizes are difficult to characterize quantitatively; however, in terms of the size of the molecules which are to be capable of passing through the pores, a realistic upper exclusion limit for macromolecules, notably biologi- cal macromolecules, such as proteins, will often be a mo- D lecular weight of the order of magnitude of 10 . The prac¬ tical lower limit for pore size will generally be set by physico-chemical considerations, e.g. the detailed chemi¬ cal structure of the outer part and the manner in which the outer part material dissolves or reacts during the po¬ re-formation process. Although possibly rather difficult to achieve, the formation of through-going pores with si¬ zes of the order of a few Angstrom would be advantageous, in that the resulting permeable conglomerate in question would be expected to be applicable as so-called "molecular sieves"; for example, a typical application of permeable conglomerates with pores of this size would be as mate¬ rials for removing traces of water from organic solvents, and the relatively large internal cavity volume of such conglomerates should confer a large drying capacity per per volume unit of conglomerate. Pore sizes may typically be formed by methods known per se, e.g. by simply controlling the concentration of the conglomerating agent. Thus, for agarose or acrylamide- de¬ rivatives a larger concentration will provide a smaller pore size. However, other methods may be applied depending on the conglomerating agent and e.g. the incorporated polymers and copolymers. "Activation or Derivatization" In cases where the conglomerating agent may not have the properties to function as an active substance, thfc conglo- merating agent, or agents, or polymers introduced in the conglomerate, may be derivatized to function as one or mo- re active substances by procedures of activation or deri- vatisation well known per se . Thus, materials comprising hydroxyl, amino, amide, carboxyl or thiol groups may be activated or derivatized using various activating che- micals, e.g. chemicals such as cyanogen bromide, divinyl sulfone, epichlorohydrine, bisepoxyranes, dibromopropanol, glutaric dialdehyde, carbodiimides, anhydrides, hydrazi- nes, periodates, benzoquinones, triazines, tosylates, tre- sylates, and diazonium ions. (d) Conglomerating Agents In selecting the conglomerating agent for use as a means of keeping the basic particles together and as a means for binding, entrapping, or carrying the active substance, the conglomerating material is to be sought among certain ty¬ pes of natural or synthetic organic polymers, and inorga¬ nic substances. "Organic Polymers" In one aspect of the invention the material of the conglo¬ merating agent comprises a member selected from the group consisting of organic monomers and polymers of biological and synthetic origin. In a preferred aspect, the conglomerating agent comprises a member selected from the group consisting of: natural and synthetic polysaccharides and other carbohy¬ drate based polymers, including agar, alginate, carragee- nan, guar gum, gum arable, gum ghatti, gum tragacanth, ka- raya gum, locust bean gum, xanthan gum, agaroses, cellulo¬ ses, pectins, mucins, dextrans, starches, heparins, and gelatins; synthetic organic monomers and polymers resulting in poly¬ mers, including acrylic polymers, polyamides, polyimides, polyesters, polyethers, polymeric vinyl compounds, polyal- kenes, and substituted derivatives thereof, as well as co¬ polymers comprising more than one such organic polymer functionality, and substituted derivatives thereof. "Inorganic Substances" In another preferred aspect, the conglomerating agent com¬ prises a member selected from the group consisting of: hydrated and anhydrous forms of silicon dioxide, in- eluding silica gel, amorphous silica and quartz; metal silicates, including silicates of lithium, so¬ dium, potassium, calcium, magnesium, aluminium and iron, and metal borosilicates, including borosili- cates of said metals; metal phosphates, including hydroxyapatite, fluorapa- tite, phosphorite and autunite; metal oxides and sulfides, including magnesium, alu¬ minium, titanium, vanadium, chromium, manganese, iron, cobalt, nickel, copper, and silver oxides, and paramagnetic metal oxides, including iron(II), iron(III), cobalt(II) and nickel(II) oxides; metal salts, including barium sulfate, and paramag¬ netic metal salts, including cobalt(II), chromi¬ um(III) and manganese(II) salts; metallic elements, including magnesium, aluminium, titanium, vanadium, chromium, manganese, indium, cop- per, silver, gold, palladium, platinum, ruthenium, osmium, rhodium and iridium, and paramagnetic me¬ tallic elements, including iron, cobalt and nickel, and alloys of metallic and paramagnetic metallic ele- ments, including alloys formed between said metallic and paramagnetic metallic elements. "The Active Substance as Conglomerating Agent" In one aspect of the invention the conglomerating agent may be omitted in the sense that the active substance it¬ self can function as a conglomerating agent. Thus, as men¬ tioned, in a preferred aspect of the invention, the active substance may e.g. function as a conglomerating agent. In this case the conglomerating agent may comprise a member selected from the group consisting of: microorganisms and enzyme systems; natural and synthetic polynucleotides and nucleic acids, including DNA, RNA, poly-A, poly-G, poly-U, poly-C and poly-T; natural and synthetic polysaccharides and other car¬ bohydrate based polymers, including agar, alginate, carrageenan, guar gum, gum arable, gum ghatti, gum tragacanth, karaya gum, locust bean gum, xanthan gum, agaroses, celluloses, pectins, mucins, dextrans, starches, heparins, and gelatins; natural and synthetic peptides and polypeptides and other amino acid based polymers, including albumins, hemoglobulins, immunoglobulins including poly- and mono clonal antibodies, antigenes, protein A, protein G, lectins, glycoproteins such as ovomucoids, biotin binding proteins e.g. avidin and streptavidin, and enzymes e.g. proteases, and protease inhibitors; special synthetic organic polymers, including spe- cifically designed acrylic polymers, polyamides, po¬ lyimides, polyesters, polyethers, polymeric vinyl compounds, polyalkenes, and substituted derivatives thereof, as well as copolymers comprising more than one such organic polymer functionality, and sub- stituted derivatives thereof; special hydrated and anhydrous forms of silicon di¬ oxide, including specifically design silica gel, amorphous silica and quartz; special metal silicates, including specifically de¬ signed silicates of lithium, sodium, potassium, cal¬ cium, magnesium, aluminium and iron, and metal boro¬ silicates, including borosilicates of said metals; special metal phosphates, including specifically de¬ signed hydroxyapatite, fluorapatite, phosphorite and autunite; special metal oxides sulfides, including specifically designed magnesium, aluminium, titanium, vanadium, chromium, manganese, iron, cobalt, nickel, copper, and silver oxides, and paramagnetic metal oxides, in¬ cluding iron(II), iron(III), cobalt(II) and ni- ckel(II) oxides; special metal salts, including specifically designed barium sulfate, and paramagnetic metal salts, includ¬ ing combalt(II), chromium(III) and mangaaese(II) salts; special metallic elements, including specifically designed magnesium, aluminium, titanium, vanadium, chromium, manganese, indium, copper, silver, gold, palladium, platinum, ruthenium, osmium, rhodium and iridium, and paramagnetic metallic elements, inclu¬ ding iron, cobalt and nickel, and alloys of metallic and paramagnetic metallic elements, including alloys formed between said metallic and paramagnetic me¬ tallic elements; and other materials used as active substance provided they can conglomerate the basic particles. "Activation or Derivatization of Conglomerating Agents" However, in cases where the conglomerating agent may not have the properties to function as an active substance, the conglomerating agent may be derivatized to function as one or more active substances by procedures of activation or derivatisation well known per se. Thus, materials com¬ prising hydroxyl, amino, amide, carboxyl or thiol groups may be activated or derivatized using various activating chemicals, e.g. chemicals such as cyanogen bromide, divin- yl sulfone, epichlorohydrine, bisepoxyranes, dibromopro- panol, glutaric dialdehyde, carbodiimides, anhydrides, hydrazines, periodates, benzoquinones, triazines, tosyla- tes, tresylates, and diazonium ions. (e) Illustration of Conglomerate Particles Fig. 1A shows a 40X amplified photograph of aspherical conglomerate particles 10 having 1-2 mm of diameter and being prepared by distibuting unicellar glass mierospheres 11 in conglomerating agarose 12 according to Example 1(a). - 50 - Fig. IB shows a 40X amplified photograph of selected sphe¬ rical conglomerate particles also prepared according to Example 1(a). Fig. IC shows a 40X amplified photograph of aspherical conglomerated particles 13 comprising a single solid glass sphere 14 and an acrylic acid copolymer 15 prepared ac¬ cording to Example 11. (f ) Fluid Bed Reactors "C Reactor" Fig.2 illustrates a cross section of a preferred embodi- ment of a fluid bed reactor 20 composed of a outer cy¬ linder 21, a top lid 22 with inlet 221 and connection for a stirrer 222, and a bottom lid 23 with outlet 231. Further, an inner cylinder 24 having holes and mounted on a support 25 attached to support blocks 251 and 252 al- lowing passage of the fluid. Stirring is performed at a suitable rate of rotation within the inner cylinder 24 to assure a sharp lower boundary 26 of the fluid bed con¬ glomerates. Without stirring, the bed of light conglomera¬ tes float against the top lid 22 and have a lower boundary 27. "T reactor" Fig. 3 illustrates a cross section of another preferred embodiment of a fluid bed reactor 30 similar to the reac¬ tor illustrated in Fig.2 except that the inner cylinder 24 is replaced by an inverse funnel 34 having an upper outlet 341 and supported by a support cylinder 35 that is open upwards. Conglomerates arriving below the funnel in the turbulens free volume will rise up through the upper outlet 341 while fluid flow down through the outlet 231. The stirrer is placed right below the surface 36 and stirring is performed at a suitable rate of rotation to provide a sharp lower boundary 37 of the conglomerates. Without stirring, the bed of light conglomerates have a lower boundary 38. "Controlled Fluid Distribution in Fluid Bed Reactors" Fig. 4A and 4B show perspective sketches of a preferred embodiment of a down flow fluid bed reactor 40. A dc-motor 41 controlled by a variable speed control 42 provides revolutions of a stirrer 43, which in a mixing zone A agitates the fluid bed particles to generate a turbulent flow of the fluid flowing down-ward. A sharp interface (generally of few particle diameters) is reached at the non-mixing zone B in which the particles are stationary and an even and smooth distribution of the fluid is obtained. In order to adapt the conditions of agitation the length of the fluid bed column can be changed by means of interchangeable chromatographic tubes 45. (A) "Down-Flow Fluid Bed Reactor" Fig. 5 shows a longitudinal section of a segment of a down-flow fluid bed reactor 50 comprising a vertical cy- Under 54 and a fluid bed A,B,C of particles 51,52,53 sus¬ pended in a down-flow fluidizing fluid 56 let in through an inlet at the top of the reactor vessel, the particles 51,52,53 having a specific gravity less than that of the fluid. A gas head 57 is above the surface along the line VIA-VIA. The upper part of the fluid bed is agitated by a plate formed mechanical stirrer 55 dividing the bed into a mix¬ ing zone A, a non-mixing zone B, and an exit zone C. In the mixing zone A, the agitated fluid bed particles 51 move dynamically which generates a turbulent flow of the fluid. The turbulence decreases down the mixing zone A. A sharp interface VIC-VIC is reached at the non-mixing zone B in which the particles 52 are in a stationary fluidized state. Across the interface VIC-VIC, the fluid flow is distributed evenly, and a smooth fluid flow is obtained in the non-mixing zone B. In the exit zone C, the pooled reacted and/or unreacted fluid 57 leave the fluid bed at an interface VID-VID, whe¬ re particles 53 can become separated from the fluid bed by the fluid flow. Figs. 6A-6C show cross sections of the mixing zone A along the lines VIB-VIB, VIC-VIC, and VID-VID, respectively, of the Fig. 5. Thus, Fig. 6A shows a cross section of essen¬ tially randomly moving particles 51, and Fig. 6B & 6C show cross sections of essentially stationary fluidized particles 52 and 53. Fig. 6D shows a cross section, along the line VIE-VIE, essentially without particles. (g) Batch Reactors In solid phase reactions, e.g. in adsorption of at least one selected substance from a fluid medium or in an enzyme reaction procedure, the reaction may be performed in a batch reactor. Generally the procedure will be to bring the conglomerate particles in contact with the liquid to be treated in a stirred tank for a certain time (the length of which is determined by the rate of adsorption of the conglomerate particles or the rate of enzymatic reac¬ tion, respectively) followed by separation of the conglo¬ merate particles from the liquid. Fig. 7 shows a collection vessel applied in a protein pu¬ rification batch process. Conglomerate particles previ¬ ously contacted with the adsorbent or reagent in the li¬ quid to be treated are pumped through the inlet valve 71 of the collection vessel 70. The low density conglomerate particles raise continuously to the top 75 of the vessel as they enter through a pipe 72 and are then trapped in the vessel (the valve 73 being closed), while the extract is leaving the vessel through the outlet valve 74. After collection of the conglomerate particles in the top section 75 of the vessel, the vessel and the particles are washed by pumping a suitable washing liquid e.g a solution of sodium chloride through the now opened valve 73 in the top and out through the outlet valve 74 in the bottom of the vessel (the valve 71 being closed). Particularly for purification and adsorption purposes, the bound adsorbent is then eluted from the conglomerate particles (still being in the top of the vessel) by pumping a suitable eluent e.g. hydrochloric acid into the vessel through valve 74 (arrow in parenthesis) in the bottom, up through the bed of conglomerate particles and out through valve 73 in the top of the vessel 75 (the valve 71 being closed and the particles being retained within the vessel by the coarse filter 76). 5. EXAMPLES All solutions employed in the following examples are aqu¬ eous solutions unless otherwise indicated. EXAMPLE 1 Preparation of conglomerates based on 3M's unicellarglass mierospheres "Glass Bubbles", B28/750, C15/250, and E22/- 400, [soda-lime-borosilicate] having a mean density of 0.28 g/cm 3, 0.15 g/cm3, and 0.22 g/cm3, respectively. (a) Low Density Agarose Hollow Glass Spheres Conglomerated Particles 300 ml soya bean oil was heated together with 3 ml sor- bitane sesquiolate to 60°C. 5 ml 6% agarose (HSA, Litex) in water was heated and 0.5 g hollow glass spheres (3 M, 3 B28/750) having a mean density of 0.28 g/cm were added under stirring. Following mixing of the agarose and glass mierospheres the suspension was added to the soya bean oil under heavily stirring. The emulsion formed was stir¬ red at about 60°C in five minutes and cooled to 20°C. The solidified agarose particles containing basic particles of hollow glass spheres were washed on a sintred glass filter with sufficient ether until all soya bean oil was removed. The conglomerate was then washed with water. The conglo¬ merate had a low density and was floating on water. (b) Low Density Agarose Hollow Glass Sphere Conglomerated Block Polymer Particles 300 ml 4% agarose was prepared by heating 12 g agarose (HSA, Litex) in 300 ml water. 9 g hollow glass spheres (C15/250, 3M) was added and the mixture was stirred until a homogeneous suspension was obtained. The suspension was cooled to 60°C under steadily stirring and the fluid sus¬ pension poured on to an efficiently cooled surface. The agarose glass sphere suspension was gelated over a short period. The gel block had a homogeneous distributed con- tent of hollow glass spheres. After cooling the gel block was blended and the granulate was sorted according to size and flow ability by means of "reverse sedimentation". (c) Low Density Poly amide Hollow Glass Sphere Conglomera- ted Particles 5 g acrylamide and 0.5 g N,N'-methylenbis(acrylamide) were dissolved in 100 ml 0.1 M potassiumhydrogenphosphate-HCl, pH 7.0. 3 g hollow glass spheres (C15/250, 3M) were added under stirring. Following the formation of a homogeneous suspension a catalyst of 1 g ammoniumpersulphate and 0.5 ml N,N,N' ,N'-tetramethylethylendiamine was added for the polymerisation. Stirring was continued until a highly vis¬ cous suspension was formed. Following polymerisation the polymer block containing hollow glass spheres was blended as described under (b). (d) Low Density Gelatin Hollow Glass Sphere Conglomerated Particles Five samples of 100 ml 5% gelatin (35°C) in 0.15 M sodium chloride were added hollow glass spheres (E22/400, 3M) in increasing amounts: After adjustment of pH to 5.5 all samples were added 2.0 ml glutaric dialdehyde (25% solution, cat.no.: 820603, Merck) under thorough stirring. After 24 hours of incuba¬ tion at room temperature the polymerized matrices were disintegrated in a blender. The resulting particles were separated from fines by reverse sedimentation (for A by sedimention as these particles were not floating). The particles were then collected on a glass filter and drain¬ ed for excess water by vacuum suction on the glass filter. The wet but drained particles were then weighed and the particle volume determined by adding a known amount of li¬ quid followed by determination of the total volume. The following particle densities were obtained: Measured Density: Calculated Density: A: 1.0 g/ml 1.00 g/ml B: 0.9 g/ml 0.93 g/ml C: 0.8 g/ml 0.85 g/ml D: 0.6 g/ml 0.63 g/ml E: 0.5 g/ml 0.57 g/ml (e) Low Density Gelatin Hollow Glass Sphere Conglomerated Particles, and Immobilization of Horse-Radish Peroxi- dase 1 g of horse-radish peroxidase (grade II, Kem-En-Tec, Den¬ mark) was dissolved in a solution of 100 ml 10% gelatin (cat.no.: G-2500, Sigma) and 0.5 M sodium chloride (35°C). 10 g hollow glass spheres (B28/750, 3M) were added under stirring. After adjustment of pH to 5.5, 2 ml glutaric dialdehyde (25% solution, cat.no.: 820603, Merck) was added with thorough stirring. The resulting gel was incubated at room temperature for 2 hours and then disintegrated in a blender. The floating particles were separated from fines and non-floating particles by inverse sedimentation. The yield of wet, packed particles was approx. 120 ml. The size range was determined to be from about 200 to about 500 μm in diameter. (f ) Low Density Gelatin Glass Sphere Conglomerated Partic¬ les, and Immobilization of Yeast Cells 50 g bakers yeast cells were suspended in a solution of 100 ml 10% gelatin and 0.15 M sodium chloride at 35 β C. The suspension was added 20 g hollow glass spheres (B28/750, 3M). After adjustment of pH to 5.5, 2 ml glutaric dialdehyde (25% solution, cat.no.: 820603, Merck) was added with stirring. After two hours of incubation at room temperature the resulting block polymer was disintegrated in a blender and the particles were washed with 5 liters of 0.15 M sodium chloride. Non-floating particles were separated from floating particles by inverse sedimentation. Approximately 200 ml of packed floating particles containing yeast cells were obtained. The size of these particles spanned from about 150 to about 750 μm. The ability of the floating immobilized yeast cells to ferment glucose was evident from the evolvement of carbon- dioxide, when incubated in a 10% glucose solution. (g) Low Density Gelatin Glass Sphere Conglomerated Partic¬ les, and Immobilization of Yeast Cells 50 g bakers yeast cells were suspended in 100 ml 10% gela¬ tin (cat.no.: G-2500, Sigma), 0.15 M sodium chloride at 35 °C. The suspension was added 20 g hollow glass spheres (B28/750, 3M). After thorough mixing the suspension was cooled by pouring onto an ice cold glassplate making the suspension into a firm gel. The resulting gel was disinte¬ grated in a blender and the particles washed with 5 liters of 0.15 M sodium chloride. Non-floating particles were separated from floating particles by inverse sedimenta¬ tion. Approximately 200 ml of packed floating particles containing yeast cells were obtained. The size of these particles spanned from about 150 to about 750 micrometers. The ability of the floating immobilized yeast cells to ferment glucose was evident from the evolvement of carbon- dioxide, when incubated in a 10% glucose solution. (h) Low Density Agar-Gelatin Glass Sphere Conglomerated Particles I 2 g agar (Bacto-agar, Difco), and 3 g gelatin (cat.no.: G- 2500, Sigma) was dissolved in 100 ml 0.15 M sodium chlo- ride by brief heating to the boiling point. After cooling to about 56 β C 10 g hollow glass beads (B28/750, 3M) were added. pH was adjusted to 4.0 with 5 M acetic acid follow¬ ed by the addition of 2 ml glutaric dialdehyde (25% solu¬ tion, Cat. No. 820603, Merck) with thorough stirring. The resulting polymer block was cooled to room temperature and incubated for 24 hours followed by disintegration in a blender. Floating particles were separated from fines and non-floa- ting particles by inverse sedimentation followed by col¬ lection of the floating particles on a glass filter. The yield of floating conglomerate particles was 95 ml packed wet particles. (i) Low Density Agar-Gelatin Glass Sphere Conglomerated Particles II 2 g agar (Bacto-agar, Gibco) and 3 g gelatin (cat.no.: G- 2500, Sigma) was dissolved in 100 ml 0.15 M sodium chlo- ride by brief heating to the boiling point. After cooling to about 56 °C 10 g hollow glass beads (B28/750, 3M) were added. The suspension was then cooled by pouring it onto an ice-cold glassplate. The resulting gel block was incu¬ bated for 24 hours at 4 β C followed by disintegration by blending in ice-water. The conglomerate floating gel-par- tides were separated from non-floating particles by in¬ verse sedimentation and then collected on a glass filter. The yield was 105 ml of packed, wet particles. The particles were then suspended in 200 ml 0.1 M potas- sium phosphate buffer pH 6.5 and crosslinked for two hours by addition of 10 ml glutaric dialdehyde (25% solution, 820603, Merck). (j) Low Density Chitosan Glass Sphere Conglomerated Parti- cles A 4% solution of chitosan (Cat. No.: 22741, Fluka) was prepared by heating 12 g chitosan in 300 ml 10% v/v acetic acid. The viscous solution was cooled to about 40 β C fol- lowed by addition of 20 g hollow glass beads (B28/750, 3M). 3 ml glutaric dialdehyde was added (25% solution, 820603, Merck) with thorough stirring. The resulting po¬ lymer block was incubated for 24 hours at room temperature followed by disintegration in a blender. The conglomerate floating gel-particles were separated from non-floating particles by inverse sedimentation in 0.1 M sodium chloride and then collected on a glass fil¬ ter. The yield was 400 ml of packed, wet particles with a diameter from about 200 μm to about 800 μm. (Ik.) Vinyltriethoxysilan Coated Glass Spheres and Poly amide Conglomerated Particles (A) "Coating of the glass spheres" 75 g (dry) hollow glass spheres (C15/250, 3M) were mixed with 500 ml 1% vinyltriethoxysilan solution in 0.1 M acetic acid and the suspension was stirred for one hour. The vinyltriethoxysilan solution was removed by filtration on a glass filter. (B) "Conglomerating acrylamide and glass spheres" 1.5 g N,N'-methylenbisacrylamide was dissolved in 10 ml ethanol and mixed with 8.5 g acrylamide dissolved in 90 ml water. 15 g vinyltriethoxysilan coated glass spheres, from (A), was added under stirring. 0.5 g ammoniumpersulphate and 0.5 ml N,N,N',N'-tetramethylethylendiamine was added as polymerisation catalysts after a homogeneous suspension was reached. The stirring was continued until the polymer block was formed. The polymer block was subsequently blended as described in Example 1(b) and "fines" were re¬ moved by "inverse sedimentation". This procedure resulted in approx. 100 ml low density conglomerate. EXAMPLE 2 Chemical Derivatisation of Low Density Agarose Glass Sphe¬ re Conglomerated Particles 10 g (dried, wet weight) agarose conglomerate spheres con¬ taining hollow glass spheres from Example 1 were suspen¬ ded in 100 ml 0.5 M potassiumphosphate/sodiumhydroxide pH 11.4. 10 ml divinyl sulfon og 50 mg sodiumborohydrid were added under stirring. The suspension was stirred at room temperature for three hours and the spheres were washed with water on a glass filter. The spheres were then acti¬ vated chemically (i.e. a method out of many possibilities) and were ready for coupling of other substances. As an ex- ample mercaptoethanol was coupled for salt-dependent chro- matopgraphy: The spheres were reacted with 5% mercapto- " ethanol in water that had been titrated to pH 9.5 with 1 M sodiumhydroxide for 3 hours at room temperature. The spheres were then washed thoroughly with destilled water and were ready to use in purification of proteins using salt-dependent chromatopgraphy. EXAMPLE 3 Purification of Human Immunoglobulin from Untreated Blood 100 g (dried, wet weight) divinylsulfon and mercaptoetha- nol treated agarose conglomerate spheres equilibrated with and suspended in 50 ml 0.75 M ammoniumsulphate were placed in a cylindrical glass column with an inner diameter of 5 cm and length of 10 cm. The glass column was sealed at the top and bottom using unscrewing plastic caps. The bottom lit had an outlet with a tube piping in the middle while the top lit had a corresponding inlet and a mechanical stirrer. The mechanical stirrer provides stirring through a air tight collar for stirring the conglomerate spheres contained in the column. The stirring propeller was desig¬ ned to avoid fluid flow that carries the agarose conglome¬ rate spheres down to the outlet in the bottom column. 2 1 unfiltrated and not centrifugated human blood (i.e. outda¬ ted blood from a blood bank) having been added ammonium¬ sulphate to a final concentration of 0.75 M is lead through the column from the top with a flow of 10 ml/min under stirring with the abovementioned stirrer (i.e. to avoid the formation of channels through the fluid bed). 2000 ml of 0,75 M ammoniumsulphate was added at the same flow rate for washing non-bound proteins and particulates. Finally, the bound proteins were eluted from the conglomerate spheres by leading 500 ml of 0.1 M sodium chloride through the column. About 5 g human immunoglobulin was eluted in the sodium chloride fraction. Qualitative analysis showed a high pu¬ rity of immunoglobulin having a very small contamination of albumin (< 1%). A corresponding purification of immunoglobulins with di- vinylsulfon and mercaptoethanol treated agarose spheres without hollow glass spheres was not possible in a tradi¬ tionally packed column because of clogging of the column by the red blood cells and other sticky materials in blood plasma. EXAMPLE 4 Immunosor tion Agarose conglomerate spheres containing 4% agarose and produced as described in Example 1 were activated with di- vinylsulfon as described in Example 2. 10 g (drained, wet weight) activated gel was coupled to rabbit immunoglobulin by incubation of the gel over night with 20 ml rabbit immunoglobulin solution (10 mg immuno- globulin/ml in 0.1 M sodiumhydrogencarbonate/sodiumhydro- xide buffer, pH 8.6 and 5% w/v polyethylenglycol MW 20,000). Excess active groups were blocked by incubation of the gel with 0.5 M ethanolamine/HCl, pH 9.0 for three hours. The gel was coupled with more than 80% of the added rabbit immunoglobulin. The floating conglomerate spheres having rabbit immunoglo¬ bulin attached could then be applied in an apparatus cor¬ responding to the one in Example 3 for adsorption of anti¬ bodies against rabbit immunoglobulin from untreated serum of previously pure rabbit immunoglobulin immunized goats. The separated antibody was of a purity and activity corre- sponding to that obtai -d with conventionally packed co- lumns using filtered a; uentrifuged antiserum. EXAMPLE 5 Preparation of Ion Exchange Conglomerates. (a) Cation Exchange Conglomerates. Conglomeration of poly- acrylic acid/ aery lamide/N ,N ' -methylen-bis ( acrylamide ) and hollow glass spheres. 300 ml destilled water was added to 25 ml acrylic acid, 100 ml ethanol, 10 g N,N'-methylen-bis(acrylamide), 25 g acrylamide, 2 g ammoniumpersulphate, 25 g hollow glass spheres (B28/750, 3M) and 2 ml N,N,N*,N'-tetramethylethy- lendiamine. The mixture was stirred until a homogeneous suspension was achieved and then titrated to pH 8.5 with 5 M sodiumhydroxide under steadily stirring. Stirring was continued until polymerisation of the suspension ocurred. Following polymerisation the block was blended as described in Example 1 (b) and "fines" were separated by means of "inverse sedimentation". Following a thoroughly wash of the particles with water, 0.1 M HCl and 0.1 M NaCl, the content of carboxyl groups in the gel was deter- mined to be about 250 μmol per g drained wet gel by sim¬ ple titration. (b) Conglomeration of Acrylic Acid/acrylamide/N,N ' -methy- leήb is acrylamide and Vinyltriethoxysilan Coated Hollow Glass Spheres 60 g (dry) hollow glass spheres (C15/250, 3M), 40 ml acry¬ lic acid, 32 g acrylamide, 8 g N,N'-methylenbisacrylamide and 5 ml vinyltriethoxysilane was added to 300 ml distil- led water. The mixture was stirred for one hour and brought to pH 7 with cold 27.4 % sodium hydroxide. 1 g am- moniumpersulphate and 1 ml N,N,N' ,N'-tetramethylethylen- diamine was added as polymerisation catalysts and stirring was continued until the polymer block was formed. The po¬ lymer block was subsequently blended as described in Ex- ample 1(b) and "fines" were removed by "inverse sedimen¬ tation". In a batch protein binding assay, pH 9, 50 mM TRIS/HCl, 1 g of drained wet conglomerate was able to bind 96% of 190 mg offered lysozyme. (c) Conglomeration of Acrylic Acid/methacrylamide/N ,N ' ' ' - methyleήbisacrylamide and Vinyltriethoxysilan Coated Hollow Glass Spheres Following the procedure described in Example 5(b), this ion exchange conglomerate was prepared as by using metha- crylamide in exchange for acrylamide. In a batch protein binding assay, pH 9, 50 mM TRIS/HCl, 1 g of the resulting drained wet conglomerate was able to bind 92% of 190 mg offered lysozyme. (d) Conglomeration of Acrylic Acid/methacrylamide/N,N ' - methylenbisacrylamide and Vinyltriethoxysilan Coated Hollow Glass Spheres Following the procedure described in Example 5(c), this ion exchange conglomerate was prepared as by using only 20 ml acrylic acid, 16 g methacrylamide and 4 g N,N'-methy- lenbisacrylamide, giving the conglomerate a lower dry weight content allowing larger proteins to diffuse in and out of the conglomerate. In a batch protein binding assay, pH 9, 50 mM TRIS/HCl, 1 g of conglomerate was able to bind 92% of 190 mg offered lysozyme. EXAMPLE 6 Immobilised Enzyme. Immobilization of glucose oxidaεe. 10 g divinylsulfon activated agarose conglomerate spheres from Example 2 were mixed with 20 ml of a solution of glu¬ cose oxidase from Aspergillus niger (10 mg/ml in 1 M po- tassiumhydrogenphosphate/sodiumhydroxide buffer, pH 10.5). The mixture was left for three hours and the uncoupled glucose oxidase was washed out of the spheres by 1 M so¬ dium chloride. The enzyme coupled conglomerate spheres showed glucose oxydase activity with glucose as a substrate. The develop¬ ment of hydrogen peroxide was detected as a brown colour¬ ing of the gel and solution by coupling the reaction with peroxidase (horse-radish peroxidase) oxidation of ortho- phenylen diamine. EXAMPLE 7 IzmπoJilization of N-acetylglucosamine for the Separation of Wheat Germ Agglutinin. Conglomerate spheres containing 4% agarose and produced as described in Example 1 (b) were activated with divinyl sulfon as described in Example 2. 10 g (dried, wet weight) of the activated gel was coupled to N-acetylglucosamine by incubating the gel over night with 20 ml 0.5 M potassium- phosphate/sodiumhydroxide buffer pH 11.5 containing 50 mg N-acetylglycosamine per ml. Following incubation the ex¬ cess of active vinyl groups were blocked by 5% mercap- toethanol titrated to pH 9.5 by sodium hydroxide. The gel was washed thoroughly with 1 M sodium chloride. The bind¬ ing capacity for wheat germ agglutinin was larger than 10 mg lectin per ml gel. EXAMPLE 8 Purification of Wheat Germ Agglutinin from a Crude Extract 200 ml of low density conglomerated agarose particles de¬ rivatized with divinyl sulfone and N-acetylglucosamine as described in Example 7 were used for purification of wheat germ agglutinin from a crude extract. The binding of the lectin was performed as an ordinary batch procedure fol- lowed by collection of the conglomerate particles, washing and elution in a specially developed collection vessel 70 shown in Fig. 7. "Extraction" A crude extract of wheat germ was prepared as follows: 1 kg wheat germ was suspended in 20 litres 0.05 M hydro¬ chloric acid at 4 °C. The suspension was stirred for 4 hours followed by separation of extract from germs by cru- de filtration through a 400 micrometer nylonfilter. The crude extract (approx. 15 litres) was adjusted to pH 5.0 with 1 M sodium hydroxide. "Adsorption and collection of affinity matrix" The low density conglomerate agarose N-acetylglucosamine particles were mixed with the crude extract and incubated with stirring for 2 hours. Following binding of the lectin to the conglomerate particles the extract (containing the particles) was pumped through the inlet valve 71 of the collection vessel 70. The low density conglomerate partic¬ les raised continuously to the top 75 of the vessel as they entered through a pipe 72 and were then trapped in the vessel (the valve 73 being closed), while the extract left the vessel through the outlet valve 74. "Washing" After collection of the conglomerate particles in the top section 75 of the vessel the vessel and the particles were washed by pumping 0.5 M sodium chloride through the now opened valve 73 in the top and out through the outlet val¬ ve 74 in the bottom of the vessel (the valve 71 being clo¬ sed). Washing was performed with 5 liters of 0.5 M sodium chloride. "Elution" Elution of the bound wheat germ agglutinin from the con¬ glomerate particles (still being in the top of the vessel) was performed by pumping ice cold 0.05 M hydrochloric acid into the vessel through valve 74 (arrow in parenthesis) in the bottom, up through the bed of conglomerate particles and out through valve 73 in the top of the vessel 75 (the valve 71 being closed and the particles being retained within the vessel by the coarse filter 76). The eluted lectin was collected in a total volume of 500 ml 0.05 M hydrochloric acid which was neutralized by the addition of 1 M dipotassium phosphate. The yield of purified wheat germ agglutinin was 360 mg. Purification of wheat germ agglutinin by traditional pack¬ ed bed chromatography would require extensive filtration and/or centrifugation as a pretreatment to avoid clogging of the column. EXAMPLE 9 Waste Water Treatment Using Immobilized Horse-Radish Per¬ oxidase Floating immobilized horse-radish peroxidase particles prepared as described in Example 1(e) were then used in a fluid bed for treatment of industrial waste water contain¬ ing a range of phenolic amines and chlorophenols. The un- treated waste water was added hydrogenperoxide to a con¬ centration of 10 mM, pH was adjusted to 5.5 and the waste water was then pumped through a down flow fluid bed column containing the floating immobilized peroxidase particles stirred proximal to the inlet as shown in Fig. 4. The bed of conglomerate peroxidase particles were divided into a mixed zone in the upper part of the fluid bed (upper 7 cm) and a zone with particles in a stationary fluidized state (lower 20 cm) by stirring with a velocity of 50 rpm and adjusting the linear flow rate of the waste water. The enzymatic oxidation and polymerization of the phenolic compounds caused heavy precipitation in the effluent and after sedimentation of the precipitate, the content of phenolics in the waste water had decreased from about 100 ppm to about 10 ppm. The heavy precipitation of polymerized phenolic compounds would have made this procedure impossible to perform due to clogging in a traditional packed bed column. Further more, the use of a stirred fluid bed compared to a non-stirred fluid bed clearly showed less formation of channels through the bed and gave a more complete reac¬ tion. EXAMPLE 10 Purification of Wastewater from the Fish Industry Using an Ion-Exchange Conglomerate Untreated wastewater from a fish fillet factory, contain¬ ing fish proteins, lipids, mucins and other organic com- pounds was filtered to remove insoluble matter and adjust¬ ed to pH 4.5 with hydrochloric acid. In order to remove the organic contaminants, a 50 litre sample of the wastewater was incubated with 2.5 litres of an acrylic acid copolymeric ion-exchange conglomerate pre¬ pared according to Example 5(d) for 2 hours. The incuba¬ tion was performed as a batch procedure and the conglome¬ rate ion-exchanger was separated from the treated waste- water by pumping it through a collecting vessel as descri¬ bed in Example 8 (fig. 7). A significant decrease in the content of organic matter after the treatment was evident from measurements of BOD. BOD values lower than 175 mg/1 were obtained. Further more, the ionexchange conglomerate became colored during the treatment from a white colour to a red-brownish colour. EXAMPLE 11 (a ) High Density Acrylic Acid Copolymer Solid Glass Sphere Conglomerated Particles To 300 ml destilled water was added 40 ml acrylic acid, 28 g acrylamide, 12 g N,N'-methylenbisacrylamide, 5 ml vinyl- triethoxysilane and 245 g solid glass spheres (0.075-0.15 mm, Fryma, Switzerland). The suspension was stirred for one hour and then adjusted to pH 7 with cold 27.4% sodium hydroxide. 1 g ammoniumpersulfate and 1 ml N,N,N' ,N'-te- tramethylethylendiamine was added as polymerization ca¬ talysts and the stirring was continued until a polymer block was formed. The polymer block was subsequently dis- integrated in a blender followed by repeated sedimentation to remove fines. This procedure gave about 800 ml conglo- merated particles with a density of 1.3 g/ml. In a batch protein binding assay (50 mM Tris/HCl pH 9.0) 1 g of wet but drained conglomerated particles was able to bind 61% of 190 mg offered lysozyme from hens egg white. Selected particles of these conglomerated particles having only one basic particle are shown in Fig. IC. (b) High Density Gelatin Solid Glass Sphere Conglomerated Particles Four samples of 100 ml 5% gelatin in 0.15 M sodium chlo¬ ride (35°C) were added solid glass spheres (0.075-.15 mm, Fryma, Switzerland) with a density of 2.5 g/ml in in- creasing amounts: A: 10 g B: 50 g C: 100 g D: 200 g After adjustment of pH to 5.5 all samples were added 2.0 ml glutaric dialdehyde (25% solution, Cat. No.: 820603, Merck) under thorough stirring. After 24 hours of incuba- tion at room temperature the polymerized matrices were disintegrated in a blender. The resulting particles were separated from fines by sedimentation. The particles were then collected on a glass filter and drained for excess water-by vacuum suction on the glass filter. The wet but drained particles were then weighed and the particle volu¬ me determined by adding a known amount of liquid followed by determination of the total volume. The following parti¬ cle densities were obtained: Measured Density: Calculated Density: 1.06 g/ml 1.25 g/ml 1.43 g/ml 1.67 g/ml

Claims: P A T E N T C L A I M S : 1. A conglomerate of controlled relative density with re- spect to a fluid, for carrying at least one active sub¬ stance to be used in the fluid, comprising predetermined amoun s of: a) basic particles consisting of at least one low density particle, and/or at least one high density particle; and b) at least one conglomerating agent. 2. A conglomerate of controlled relative density with re- spect to a fluid, carrying at least one active substance to be used in the fluid, comprising predetermined amounts of: a) basic particles consisting of at least one low density particle, and/or at least one high density particle; b) at least one conglomerating agent; and c) said active substance. 3. A conglomerate according to claims 1-2, wherein the basic particles constitute more than one basic particle. 4. A conglomerate according to any of claims 1-3, wherein said basic particles are impermeable to the fluid. 5. A conglomerate according to any of claims 1-4, wherein the low density particles are hollow. 6. A conglomerate according to any of claims 1-4, wherein the high density particles are solid. 7. A conglomerate according to any of claims 1-6, wherein the basic particles constitute from 1 to 95 %, generally from 1.5 to 75 %, particularly from 5 to 50 %, preferably from 5 to 40 %, and most preferably from 5 to 30 %, by volume of the conglomerate. 8. A conglomerate according to any of claims 1-7, wherein the basic particles are made of a material selected from the group consisting of natural and synthetic organic polymers, inorganic substances and compounds, metallic elements and alloys thereof, and non-metallic elements, and gas bubbles. 9. A conglomerate according to claim 8, wherein the synthetic organic polymers are selected from the group consisting of: resins of the phenol-formaldehyde type; ABS resins; polyamides, polyimides, polyesters, polyethers, poly¬ meric vinyl compounds, polyalkenes, and substituted derivatives thereof; and copolymers comprising more than one such said poly¬ mers, and substituted derivatives of such copolymers. 10. A conglomerate according to claim 8, wherein the in- organic substances and compounds, metallic elements and alloys thereof, and non-metallic elements are selected from the group consisting of: anhydrous forms of silicon dioxide, including amor- phous silica and quartz; metal silicates, including silicates of lithium, so¬ dium, . potassium, calcium, magnesium, aluminium and iron, and metal borosilicates, such as borosilicates of said metals, metal phosphates, including hydroxy- apatite, fluorapatite, phosphorite and autunite; metal oxides and sulfides, including magnesium, alu¬ minium, titanium, vanadium, chromium, manganese, iron, cobalt, nickel, copper and silver oxides; non-metal oxides, including boric oxide; metal salts, including barium sulfate; metallic elements, including magnesium, aluminium, titanium, vanadium, chromium, manganese, iron, co¬ balt, nickel, indium, copper, silver, gold, palla¬ dium, platinum, ruthenium, osmium, rhodium and iri- dium, and alloys of metallic elements, such as alloys formed between said metallic elements; crystalline and amorphous forms of carbon, including graphite, carbon black and charcoal. 11. A conglomerate according to claim 8 having a density larger than one, wherein the basic particles are made of a material selected from non-magnetic materials. 12. A conglomerate according to claim 8, wherein the gas bubbles are selected from the group consisting of: a) air; nitrogen; carbon dioxide; and b) inert gases, including He, Ne, Ar, and Xe. 13. A conglomerate according to any of claims 1-12, wherein the low density particles consist of hollow plastic particles, or unicellar glass micro spheres. 14. A conglomerate according to any of claims 1-12, wherein the high density particles consist of glass particles, preferably glass micro spheres. 15. A conglomerate according to any of claims 1-14, wherein the conglomerating agent is made of a material selected from a group consisting of natural or synthetic organic monomers and polymers, and inorganic substances. 16. A conglomerate according to claim 15, wherein the na¬ tural and synthetic organic monomers and polymers are se¬ lected from the group consisting of: a) natural and synthetic polysaccharides and other carbo¬ hydrate based polymers, including agar, alginate, car- rageenan, guar gum, gum arable, gum ghatti, gum traga- canth, karaya gum, locust bean gum, xanthan gum, agaro- ses, celluloses, pectins, mucins, dextrans, starches, heparins, gelatins, chitosans, hydroxy starches, hy¬ droxypropyl starches, carboxymethyl starches, hydroxy- ethyl celluloses, hydroxypropyl celluloses, and carboxymethyl celluloses; b) synthetic organic polymers and monomers resulting in polymers, including acrylic polymers, polyamides, poly¬ imides, polyesters, polyethers, polymeric vinyl com¬ pounds, polyalkenes, and substituted derivatives the- reof, as well as copolymers comprising more than one such organic polymer functionality, and substituted de¬ rivatives thereof; and c) mixtures of these. 17. A conglomerate acording to claim 15, wherein the in¬ organic substances are selected from the group according to claim 10. 18. A conglomerate according to any of claims 1-17, whe¬ rein the active substance comprises a material or mixtures of materials selected from the group consisting of: organic and inorganic compounds or ions; metallic elements and alloys thereof; non-metallic elements; organic polymers of biological and synthetic origin; membrane-enclosed structures; biological cells; and virus particles. 19. A conglomerate according to claim 1-18, wherein the active substance comprises a member selected from the group consisting of: ligands known per se in the field of chromatography, e.g. charged species i.a. for ion exhange chromato- graphy; proteins, dyes, enzyme inhibitors, specific ligands for specific proteins, e.g. biotin for puri¬ fication of avidin and other biotin binding proteins, carbohydrates for purification of lectins or gly- cosidases, protein A, chelates, e.g. iminouiacetic acid; amino acids, e.g. arginine, lysine, and histi- dine; sulfated polymers including e.g. heparins; gelatins; benzhydroxamic acid; hydrophobic ligands, e.g. phenyl, hydrocarbons such as octyl amiήe, octa- nol; thiophilic ligands, i.e. divinyl sulfone activated substances coupled with mercaptoethanol or 4-hydroxy-pyridine, 3-hydroxy-pyridine, 2-hydroxy- pyridine; lipid vesicles; microorganisms and enzyme systems; virus particles, including attenuated and inactivated virus particles; natural and synthetic polynucleotides and nucleic acids, including DNA, RNA, poly-A, poly-G, poly-U, poly-C and poly-T; natural and synthetic polysaccharides and other car- bohydrate based polymers, including agar, alginate, carrageenan, guar gum, gum arable, gum ghatti, gum tragacanth, karaya gum, locust bean gum, xanthan gum, agaroses, celluloses, pectins, mucins, dextrans, starches, heparins, and gelatins; natural and synthetic peptides and polypeptides and other amino acid based polymers, including albumins, hemoglobulins, immunoglobulins including poly- and mono clonal antibodies, antigenes, protein A, protein G, lectins, glycoproteins such as ovomucoids, biotin binding proteins e.g. avidin and streptavidin, and enzymes e.g. proteases, and protease inhibitors; synthetic organic polymers, including acrylic poly- mers, polyamides, polyimides, polyesters, polyethers, polymeric vinyl compounds, polyalkenes, anc substituted derivatives thereof, as well as copoly¬ mers comprising more than one such organic polymer functionality, and substituted derivatives of such copolymers; food, medicals, and vaccines for fish and other ani¬ mals living in water; hydrated and anhydrous forms of silicon dioxide, in- eluding silica gel, amorphous silica and quartz; metal silicates, including silicates of lithium, sodium, potassium, calcium, magnesium, aluminium and iron, and metal borosilicates, including boro- silicates of said metals; metal phosphates, including hydroxyapatite, fluor- apatite, phosphorite and autunite; metal oxides, including magnesium, aluminium, ti¬ tanium, vanadium, chromium, manganese, iron, cobalt, nickel, copper, and silver oxides, and paramagnetic metal oxides, including -iron(II), iron(III), cobalt(II) and nickel(II) oxides; metal salts, including barium sulfate, and para¬ magnetic metal salts, including combalt(II), chro- mium(III) and manganese(II) salts; metallic elements, including magnesium, aluminium, titanium, vanadium, chromium, manganese, indium, copper, silver, gold, palladium, platinum, ruthenium, osmium, rhodium and iridium, and paramagnetic metallic elements, including iron, cobalt and nickel, and alloys of metallic and paramagnetic metallic elements, including alloys formed between said metallic and paramagnetic metallic elements; and mixtures of these. 20. A conglomerate according to any of claims 1-19, whe¬ rein the active substance or the conglomerate is activated or derivatized by means of activation or derivatisation agents. 21. A conglomerate according to claim 20, wherein the activation or derivatisation agent is selected from a group consisting of: cyanogen bromide, divinyl sulfone, epichlorohydrine, bisepoxyranes, dibromopropanol, glutaric dialdehyde, carbodiimides, anhydrides, hydrazines, periodates, benzoquinones, triazines, tosylates, tresyl- ates, and diazonium ions. 22. A conglomerate according to any of claims 1-21, wherein the basic particles are attached to the conglo- merating agent by an adhesive agent, preferably selected from a group consisting of: vinyltrimethoxysi1ane, epoxypropy1trimethoxysi1ane, aminopropyltrimethoxysilane; and vinyltriethoxysilane, epoxypropyltriethoxysilane, aminopropyltriethoxysilane. 23. A conglomerate according to any of claims 1-22, whe- rein the relative density is chosen from 0.1 to 15, parti¬ cularly from 0.1 to 5, and preferably from 0.2 to 2. 24. A conglomerate according to any of claims 1-22, whe¬ rein the relative density is chosen from 1 to 15, par- ticularly from 1.1 to 5, and preferably from 1.1 to 2. 25. A conglomerate according to any of claims 1-22, whe¬ rein the relative density is chosen from 0.1 to 1, gene¬ rally from 0.2 to 0.95, particularly from 0.3 to 0.8, and preferably from 0.5 to 0.75. 26. A conglomerate according to claims 1-25, wherein the size of the conglomerate is within a range selected from the group consisting of: 27. A conglomerate according to claim 26, particularly for purification and binding proteins and other high mo- lecular weight substances, wherein the size of the conglo¬ merate is within a range selected from the groups consis¬ ting of: 100-500 μm, most preferred. 28. A conglomerate according to claim 26, particularly for purification and binding of proteins and other high molecular weight substances in a batch process, wherein the size of the conglomerate is within a range selected from the groups of: 1-2000 μm, 250-2000 μm, 500-2000 μm, 500-1000 μm, most preferred. 29. A conglomerate according to claim 26, particularly for enzyme reactions, wherein the size of the conglomerate is within a range selected from the groups consisting of: 50-5000 μm, 200-1000 μm, most preferred. 30. A conglomerate according to claim 26, particularly for immobilisation of microorganims, wherein the size of the conglomerate is within a range selected from the group consisting of: 0.5-50 mm, 0.5-10 mm, 0.5-5 mm, most preferred. 31. A method of preparing a conglomerate of controlled relative density with respect to a fluid, for carrying or carrying at least one active substance to be used in the fluid, comprising: a) mixing basic particles consisting of at least one low density particle, preferably hollow, and/or at least one high density particle, said particles preferably impermeable to the fluid, at least one conglomerating agent made according to any of claims 15-17, said active substance, if present, in predetermined amounts optionally heated; b) emulsifying said mixture in a suitable solvent; c) conglomerating by a suitable means such as gelation by heating/cooling, polymerisation of monomer or monomer mixtures, non-covalent or covalent cross-bonding; and d) isolation and washing of the conglomerate. 32. A method of preparing a conglomerate of controlled relative density with respect to a fluid, for carrying or carrying at least one active substance to be used in the fluid, comprising: a) mixing basic particles consisting of at least one low density particle, preferably hollow, and/or at least one high density particle, said particles preferably impermeable to the fluid, at least one conglomerating agent made according to any of claims 15-17, said active substance, if present, in predetermined amounts in a solvent; b) conglomerating by a suitable means such as gelation by heating/cooling, polymerisation of monomer or monomer mixtures, non-covalent or covalent cross-bonding; c) disintegrating the block of conglomerate; and d) segregating the particles, and washing the segregated conglomerate. 33. The use of a conglomerate or particles of a conglome¬ rate according to any of claims 1-30, or a conglomerate prepared by a method of preparing a conglomerate according to any of claims 31-32, as a solid phase matrix, carrier, or substrate material in a procedure selected from a group consisting of: chromatographic procedures applying non-packed co¬ lumns including liquid chromatography, ion-exchange chromatography, and biospecific affinity chromato¬ graphy such as immunosorption and protein A chromato¬ graphy, and group specific affinity chromatography such as hydrophobic, thiophilic, dye, lectin, and me¬ tal chelate chromatography; filtration of a fluid medium; adsorption of at least one selected substance present in a fluid medium; heterogeneous catalysis of a reaction taking place in a fluid medium; immunochemical procedures, including immunosorbtion; solid-phase synthesis, including solid-phase peptide and protein synthesis, and solid-phase oligonu- cleotide synthesis; microbiological procedures; enzyme reactor procedures; carriage, on the outer or the interior surface of the particles, optionally after a suitable surface treat¬ ment of live cells selected from cells of human. animal, plant, fungal and microorganism origin. 34. The use of a conglomerate or particles of a conglome¬ rate according to any of claims 1-30, or a conglomerate prepared by a method of preparing a conglomerate according to any of claims 31-32, as a solid phase matrix, carrier, or substrate material in a fluid bed reactor. 35. The use of a conglomerate or particles of a conglome- rate according to any of claim 1-30, a conglomerate prepa¬ red by a method of preparing a conglomerate according to any of claims 31-32, as a solid phase matrix, carrier, or substrate material in a batch reactor. 36. The use of a conglomerate or particles of a conglome¬ rate according to any of claims 1-30, or a conglomerate prepared by a method of preparing a conglomerate according to any of claims 31-32, as a carrier of substances for sustained release. 37. The use of a conglomerate or particles of a conglome¬ rate according to any of claims 1-30, or a conglomerate prepared by a method of preparing a conglomerate according to any of claims 31-32, as a food material, medical, or vaccine for fish, or other animals living in water. 38. The use of a conglomerate or particles of a conglome¬ rate according to any of claims 1-30, or a conglomerate prepared by a method of preparing a conglomerate according to any of claims 31-32, as a material for treating waste water. 39. The use of a conglomerate or particles of a conglome¬ rate according to any of claims 1-30, or a conglomerate prepared by a method of preparing a conglomerate according to any of claims 31-32, as a material for treating pollu- ted water such as oil polluted sea water. 40. A method of distributing a fluid in a down flow fluid bed reactor comprising a vertical reactor with an inlet, an outlet, and a fluid bed of particles, wherein the particles proximal to the fluid inlet are agitated, pre¬ ferably by stirring with a mechanical stirrer which does not form a vortex, forming a mixing zone of dynamical particles adjoining a non-mixing zone of particles in a stationary fluidized state, said mixing zone having an extent determined by the degree of agitation the value of which is selected for a given flow of fluid, viscosity, and buoyancy of the particles, within a range from a degree of agitation where the particles move but to not mix to a degree of agitation where the particles mix throughout the fluid bed. 41. A method of distributing a fluid in a up flow fluid bed reactor comprising a vertical reactor with an inlet, an outlet, and a fluid bed of particles, wherein the particles proximal to the fluid inlet are agitated, pre¬ ferably by stirring with a mechanical stirrer which does not form a vortex, forming a mixing zone of dynamical particles adjoining a non-mixing zone of particles in a stationary fluidized state, said mixing zone having an extent determined by the degree of agitation the value of which is selected for a given flow of fluid, viscosity, and sedimentation of the particles, within a range from a degree of agitation where the particles move but to not mix to a degree of agitation where the particles mix throughout the fluid bed. 42. A method according to claims 40 and 41, wherein said particles consist of a conglomerate or particles of a con- glomerate according to claims 1-30, or a conglomerate pre¬ pared by a method of preparing a conglomerate according to any of claims 31-32. 43. A down flow fluid bed reactor comprising a vertical reactor vessel with an inlet, an outlet; a fluid bed of particles; and agitation means, preferably a mechanical stirrer which does not form a vortex, agitating the par¬ ticles proximal to the fluid inlet so that a mixing zone of dynamical particles adjoining a non-mixing zone of particles in a stationary fluidized state, said mixing zone having an extent determined by the degree of agita¬ tion the value of which is selected for a given flow of fluid, viscosity, and buoyancy of the particles, within a range from a degree of agitation where the particles move but to not mix to a degree of agitation where the partic- les mix throughout the fluid bed. 44. An up flow fluid bed reactor comprising a vertical reactor vessel with an inlet, an outlet; a fluid bed of particles; and agitation means, preferably a mechanical stirrer which does not form a vortex, agitating the par¬ ticles proximal to the fluid inlet so that a mixing zone of dynamical particles adjoining a non-mixing zone of particles in a stationary fluidized state, said mixing zone having an extent determined by the degree of agita- tion the value of which is selected for a given flow of fluid, viscosity, and sedimentation of the particles, within a range from a degree of agitation where the par¬ ticles move but to not mix to a degree of agitation where the particles mix throughout the fluid bed. 45. A reactor according to claims 43 and 44, wherein said particles consist of a conglomerate or particles of a con¬ glomerate according to claims 1-30, or a conglomerate pre¬ pared by a method of preparing a conglomerate according to any of claims 31-32.

Inventors: BOEG-HANSEN THORKILD CHRISTIAN, LIHME ALLAN OTTO FOG, NIELSEN CLAUS SCHAEFER, BOEG-HANSEN, THORKILD, CHRISTIAN, LIHME, ALLAN, OTTO, FOG, NIELSEN, CLAUS, SCHAEFER
Applicants: KEM EN TEC AS, KEM-EN-TEC A/S
Application year: 1991
Main classification: B01J2
IPC codes: B01D15, B01D39, B01J2, B01J8, B01J13, B01J20, B01J47, C02F1, C02F3, C07B63, C08K3, C08K5, C08L101, C12M1, G01N30